#SampleID	BarcodeSequence	LinkerPrimerSequence	TubeID	SubjectID	SampleType	HostSpecies	study_day	study_group	Household	current_antibiotics	time_collected	plate	plate_location_combined	dna_concentration_ng_ul	extraction_notes	polymerase	library_concentration_ng_ul	remade_library_concentration_ng_ul	final_library_concentration_ng_ul	volume_for_pool	volume_for_epmotion	pooled	flow_cell_id	run_start_date	investigator	DNA_plate_barcode	Lib_plate_barcode	reverse_barcode_seq	forward_barcode_seq	Population	Condition	ExtractionRun	Meth	reextracted_dna_concentration_ng_ul	final_dna_concentration_ng_ul	Description
control3	ATCTCTGGCATAGAACGGGACGTA	GGACTACNVGGGTWTCTAAT	NA	NA	extraction control	NA	NA	NA	NA	NA	NA	CW.LD Plate 2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	run0719	N	NA	NA	000000000-C8T38
control4	ATCTCTGGCATATCTGAGGTTGCC	GGACTACNVGGGTWTCTAAT	NA	NA	control	NA	NA	NA	NA	NA	NA	CW.LD Plate 2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	run0719	N	NA	NA	000000000-C8T38
control5	ATCTCTGGCATAAATAGCATGTCG	GGACTACNVGGGTWTCTAAT	NA	NA	extraction control	NA	NA	NA	NA	NA	NA	CW.LD Plate 2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	run0719	N	NA	NA	000000000-C8T38
DNAfreewater1	GTAAGTCGTGGCCTGGGTATCTCG	GGACTACNVGGGTWTCTAAT	NA	NA	DNA-free water	NA	NA	NA	NA	NA	NA	P1	A04	NA	Customer Extracted	Q5	0.09	NA	0.09	333.3	1	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	CTGGGTATCTCG	GTAAGTCGTGGC	NA	NA	NA	N	NA	NA	000000000-CD29D
DNAfreewater2	TGTGAGCACGGTTATCCAAGCGCA	GGACTACNVGGGTWTCTAAT	NA	NA	DNA-free water	NA	NA	NA	NA	NA	NA	P2	C09	NA	Customer Extracted	Q5	0.04	NA	0.04	750	1	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	TATCCAAGCGCA	TGTGAGCACGGT	NA	NA	NA	N	NA	NA	000000000-CD29D
DNAfreewater3	TGTGAGCACGGTAAGTCACACACA	GGACTACNVGGGTWTCTAAT	NA	NA	DNA-free water	NA	NA	NA	NA	NA	NA	P2	E12	NA	Customer Extracted	Q5	0.07	NA	0.07	428.6	1	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	AAGTCACACACA	TGTGAGCACGGT	NA	NA	NA	N	NA	NA	000000000-CD29D
DNAfreewater4	CTGGAAATCTGCTATCCAAGCGCA	GGACTACNVGGGTWTCTAAT	NA	NA	DNA-free water	NA	NA	NA	NA	NA	NA	P3	C09	NA	Customer Extracted	Q5	0.04	NA	0.04	750	1	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	TATCCAAGCGCA	CTGGAAATCTGC	NA	NA	NA	N	NA	NA	000000000-CD29D
DNAfreewater5	CTGGAAATCTGCAAGTCACACACA	GGACTACNVGGGTWTCTAAT	NA	NA	DNA-free water	NA	NA	NA	NA	NA	NA	P3	E12	NA	Customer Extracted	Q5	0.04	NA	0.04	750	1	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	AAGTCACACACA	CTGGAAATCTGC	NA	NA	NA	N	NA	NA	000000000-CD29D
DNAfreewater6	TGAGGATGATAGTATCCAAGCGCA	GGACTACNVGGGTWTCTAAT	NA	NA	DNA-free water	NA	NA	NA	NA	NA	NA	P4	C09	0	Customer Extracted	Q5	0.08	NA	0.08	375	1	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	TATCCAAGCGCA	TGAGGATGATAG	NA	NA	NA	N	NA	0	000000000-CD29D
DNAfreewater7	TGAGGATGATAGAAGTCACACACA	GGACTACNVGGGTWTCTAAT	NA	NA	DNA-free water	NA	NA	NA	NA	NA	NA	P4	E12	0	Customer Extracted	Q5	0.08	NA	0.08	375	1	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	AAGTCACACACA	TGAGGATGATAG	NA	NA	NA	N	NA	0	000000000-CD29D
DNAfreewaterO2	ATCTCTGGCATATATCCAAGCGCA	GGACTACNVGGGTWTCTAAT	NA	NA	DNA-free water	NA	NA	NA	NA	NA	NA	CW.LD Plate 2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	run0719	N	NA	NA	000000000-C8T38
ExtractionControl	GTAAGTCGTGGCCTTGAGAAATCG	GGACTACNVGGGTWTCTAAT	NC	NA	Lab water	NA	NA	NA	NA	NA	NA	P1	A05	NA	Customer Extracted	Q5	0.2	NA	0.2	150	35	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	CTTGAGAAATCG	GTAAGTCGTGGC	NA	NA	NA	N	NA	NA	000000000-CD29D
geneblock1	GTAAGTCGTGGCAACCAAACTCGA	GGACTACNVGGGTWTCTAAT	NA	NA	Mock DNA	NA	NA	NA	NA	NA	NA	P2	G03	NA	Customer Extracted	Q5	52.02	NA	52.02	0.6	1	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	AACCAAACTCGA	GTAAGTCGTGGC	NA	NA	NA	N	NA	NA	000000000-CD29D
geneblock2	TGTGAGCACGGTAACCAAACTCGA	GGACTACNVGGGTWTCTAAT	NA	NA	Mock DNA	NA	NA	NA	NA	NA	NA	P2	G03	NA	NA	Q5	40.07	NA	40.07	0.7	1	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	AACCAAACTCGA	TGTGAGCACGGT	NA	NA	NA	N	NA	NA	000000000-CD29D
geneblock3	TGTGAGCACGGTCTGGGTATCTCG	GGACTACNVGGGTWTCTAAT	NA	NA	Mock DNA	NA	NA	NA	NA	NA	NA	P2	A04	NA	NA	Q5	39.12	NA	39.12	0.8	1	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	CTGGGTATCTCG	TGTGAGCACGGT	NA	NA	NA	N	NA	NA	000000000-CD29D
geneblock4	CTGGAAATCTGCAACCAAACTCGA	GGACTACNVGGGTWTCTAAT	NA	NA	Mock DNA	NA	NA	NA	NA	NA	NA	P3	G03	NA	Customer Extracted	Q5	39.4	NA	39.4	0.8	1	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	AACCAAACTCGA	CTGGAAATCTGC	NA	NA	NA	N	NA	NA	000000000-CD29D
geneblock5	CTGGAAATCTGCCTGGGTATCTCG	GGACTACNVGGGTWTCTAAT	NA	NA	Mock DNA	NA	NA	NA	NA	NA	NA	P3	A04	NA	Customer Extracted	Q5	39.43	NA	39.43	0.8	1	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	CTGGGTATCTCG	CTGGAAATCTGC	NA	NA	NA	N	NA	NA	000000000-CD29D
geneblock6	TGAGGATGATAGAACCAAACTCGA	GGACTACNVGGGTWTCTAAT	NA	NA	Mock DNA	NA	NA	NA	NA	NA	NA	P4	G03	0	Customer Extracted	Q5	35.53	NA	35.53	0.8	1	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	AACCAAACTCGA	TGAGGATGATAG	NA	NA	NA	N	NA	0	000000000-CD29D
geneblock7	TGAGGATGATAGCTGGGTATCTCG	GGACTACNVGGGTWTCTAAT	NA	NA	Mock DNA	NA	NA	NA	NA	NA	NA	P4	A04	0	Customer Extracted	Q5	35.42	NA	35.42	0.8	1	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	CTGGGTATCTCG	TGAGGATGATAG	NA	NA	NA	N	NA	0	000000000-CD29D
I.03.1.GnAp.5	TGTGAGCACGGTGATGCTGCCGTT	GGACTACNVGGGTWTCTAAT	11	F3.1	FACS	Human	NA	Case	F3	NA	42619	P2	C02	NA	Customer Extracted	Q5	13.16	NA	13.16	2.3	2.3	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	GATGCTGCCGTT	TGTGAGCACGGT	IgA+IgG-	5A	run1	Y	NA	NA	000000000-CD29D
I.03.1.GnMp.5	TGTGAGCACGGTACGTGTAGGCTT	GGACTACNVGGGTWTCTAAT	8	F3.1	FACS	Human	NA	Case	F3	NA	42619	P2	H01	NA	Customer Extracted	Q5	9.58	NA	9.58	3.1	3.1	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	ACGTGTAGGCTT	TGTGAGCACGGT	IgM+IgG-	5A	run1	Y	NA	NA	000000000-CD29D
I.03.1.GpAn.5	TGTGAGCACGGTGGTCTCCTACAG	GGACTACNVGGGTWTCTAAT	9	F3.1	FACS	Human	NA	Case	F3	NA	42619	P2	A02	NA	Customer Extracted	Q5	11.36	NA	11.36	2.6	2.6	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	GGTCTCCTACAG	TGTGAGCACGGT	IgG+IgA-	5A	run1	Y	NA	NA	000000000-CD29D
I.03.1.GpAp.5	TGTGAGCACGGTACTGACTTAAGG	GGACTACNVGGGTWTCTAAT	10	F3.1	FACS	Human	NA	Case	F3	NA	42619	P2	B02	NA	Customer Extracted	Q5	9.79	NA	9.79	3.1	3.1	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	ACTGACTTAAGG	TGTGAGCACGGT	IgG+IgA+	5A	run1	Y	NA	NA	000000000-CD29D
I.03.1.GpMn.5	TGTGAGCACGGTGAGAGTCCACTT	GGACTACNVGGGTWTCTAAT	6	F3.1	FACS	Human	NA	Case	F3	NA	42619	P2	F01	NA	Customer Extracted	Q5	7.85	NA	7.85	3.8	3.8	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	GAGAGTCCACTT	TGTGAGCACGGT	IgG+IgM-	5A	run1	Y	NA	NA	000000000-CD29D
I.03.1.GpMp.5	TGTGAGCACGGTGAACGGGACGTA	GGACTACNVGGGTWTCTAAT	7	F3.1	FACS	Human	NA	Case	F3	NA	42619	P2	G01	NA	Customer Extracted	Q5	12.62	NA	12.62	2.4	2.4	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	GAACGGGACGTA	TGTGAGCACGGT	IgG+IgM+	5A	run1	Y	NA	NA	000000000-CD29D
I.03.1.MnAp.4	TGTGAGCACGGTCTTAGGCATGTG	GGACTACNVGGGTWTCTAAT	4	F3.1	FACS	Human	NA	Case	F3	NA	42619	P2	D01	NA	Customer Extracted	Q5	10.75	NA	10.75	2.8	2.8	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	CTTAGGCATGTG	TGTGAGCACGGT	IgA+IgM-	4A	run1	Y	NA	NA	000000000-CD29D
I.03.1.MpAn.4	TGTGAGCACGGTCGATAGGCCTTA	GGACTACNVGGGTWTCTAAT	2	F3.1	FACS	Human	NA	Case	F3	NA	42619	P2	B01	NA	Customer Extracted	Q5	6.82	NA	6.82	4.4	4.4	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	CGATAGGCCTTA	TGTGAGCACGGT	IgM+IgA-	4A	run1	Y	NA	NA	000000000-CD29D
I.03.1.MpAp.4	TGTGAGCACGGTAATGACCTCGTG	GGACTACNVGGGTWTCTAAT	3	F3.1	FACS	Human	NA	Case	F3	NA	42619	P2	C01	NA	Customer Extracted	Q5	3.91	NA	3.91	7.7	7.7	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	AATGACCTCGTG	TGTGAGCACGGT	IgM+IgA+	4A	run1	Y	NA	NA	000000000-CD29D
I.03.1.Neg.4	TGTGAGCACGGTACTCTAGCCGGT	GGACTACNVGGGTWTCTAAT	1	F3.1	FACS	Human	NA	Case	F3	NA	42619	P2	A01	NA	Customer Extracted	Q5	0.92	NA	0.92	32.6	32.6	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	ACTCTAGCCGGT	TGTGAGCACGGT	IgA-IgM-IgG-	4A	run1	Y	NA	NA	000000000-CD29D
I.03.1.Neg.5	TGTGAGCACGGTCCAGATATAGCA	GGACTACNVGGGTWTCTAAT	5	F3.1	FACS	Human	NA	Case	F3	NA	42619	P2	E01	NA	Customer Extracted	Q5	5.34	NA	5.34	5.6	5.6	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	CCAGATATAGCA	TGTGAGCACGGT	IgA-IgM-IgG-	5A	run1	Y	NA	NA	000000000-CD29D
I.03.2.GnMp.5	TGTGAGCACGGTATGGGCGAATGG	GGACTACNVGGGTWTCTAAT	17	F3.2	FACS	Human	NA	Case	F3	NA	42619	P2	A03	NA	Customer Extracted	Q5	16.73	NA	16.73	1.8	1.8	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	ATGGGCGAATGG	TGTGAGCACGGT	IgM+IgG-	5A	run1	Y	NA	NA	000000000-CD29D
I.03.2.GpMn.5	TGTGAGCACGGTACAGCTCAAACA	GGACTACNVGGGTWTCTAAT	15	F3.2	FACS	Human	NA	Case	F3	NA	42619	P2	G02	NA	Customer Extracted	Q5	15.14	NA	15.14	2	2	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	ACAGCTCAAACA	TGTGAGCACGGT	IgG+IgM-	5A	run1	Y	NA	NA	000000000-CD29D
I.03.2.GpMp.5	TGTGAGCACGGTGAGCGTATCCAT	GGACTACNVGGGTWTCTAAT	16	F3.2	FACS	Human	NA	Case	F3	NA	42619	P2	H02	NA	Customer Extracted	Q5	11.05	NA	11.05	2.7	2.7	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	GAGCGTATCCAT	TGTGAGCACGGT	IgG+IgM+	5A	run1	Y	NA	NA	000000000-CD29D
I.03.2.MpAn.4	TGTGAGCACGGTATTAAGCCTGGA	GGACTACNVGGGTWTCTAAT	13	F3.2	FACS	Human	NA	Case	F3	NA	42619	P2	E02	NA	Customer Extracted	Q5	6.63	NA	6.63	4.5	4.5	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	ATTAAGCCTGGA	TGTGAGCACGGT	IgM+IgA-	4A	run1	Y	NA	NA	000000000-CD29D
I.03.2.Neg.4	TGTGAGCACGGTTTCCTAGGCCAG	GGACTACNVGGGTWTCTAAT	12	F3.2	FACS	Human	NA	Case	F3	NA	42619	P2	D02	NA	Customer Extracted	Q5	7.32	NA	7.32	4.1	4.1	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	TTCCTAGGCCAG	TGTGAGCACGGT	IgA-IgM-IgG-	4A	run1	Y	NA	NA	000000000-CD29D
I.03.2.Neg.5	TGTGAGCACGGTTGGCTTTCTATC	GGACTACNVGGGTWTCTAAT	14	F3.2	FACS	Human	NA	Case	F3	NA	42619	P2	F02	NA	Customer Extracted	Q5	10.68	NA	10.68	2.8	2.8	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	TGGCTTTCTATC	TGTGAGCACGGT	IgA-IgM-IgG-	5A	run1	Y	NA	NA	000000000-CD29D
I.11.1.GnMp.5	TGTGAGCACGGTTAACGCTGTGTG	GGACTACNVGGGTWTCTAAT	22	F11.1	FACS	Human	NA	Control	F11	NA	51019	P2	F03	NA	Customer Extracted	Q5	13.2	NA	13.2	2.3	2.3	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	TAACGCTGTGTG	TGTGAGCACGGT	IgM+IgG-	5A	run1	Y	NA	NA	000000000-CD29D
I.11.1.GpMp.5	TGTGAGCACGGTATAGCGAACTCA	GGACTACNVGGGTWTCTAAT	21	F11.1	FACS	Human	NA	Control	F11	NA	51019	P2	E03	NA	Customer Extracted	Q5	11.45	NA	11.45	2.6	2.6	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	ATAGCGAACTCA	TGTGAGCACGGT	IgG+IgM+	5A	run1	Y	NA	NA	000000000-CD29D
I.11.1.MpAn.4	TGTGAGCACGGTCATCATACGGGT	GGACTACNVGGGTWTCTAAT	19	F11.1	FACS	Human	NA	Control	F11	NA	51019	P2	C03	NA	Customer Extracted	Q5	4.33	NA	4.33	6.9	6.9	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	CATCATACGGGT	TGTGAGCACGGT	IgM+IgA-	4A	run1	Y	NA	NA	000000000-CD29D
I.11.1.Neg.4	TGTGAGCACGGTGATCTCTGGGTA	GGACTACNVGGGTWTCTAAT	18	F11.1	FACS	Human	NA	Control	F11	NA	51019	P2	B03	NA	Customer Extracted	Q5	6.28	NA	6.28	4.8	4.8	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	GATCTCTGGGTA	TGTGAGCACGGT	IgA-IgM-IgG-	4A	run1	Y	NA	NA	000000000-CD29D
I.11.1.Neg.5	TGTGAGCACGGTTACGGATTATGG	GGACTACNVGGGTWTCTAAT	20	F11.1	FACS	Human	NA	Control	F11	NA	51019	P2	D03	NA	Customer Extracted	Q5	9.24	NA	9.24	3.2	3.2	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	TACGGATTATGG	TGTGAGCACGGT	IgA-IgM-IgG-	5A	run1	Y	NA	NA	000000000-CD29D
I.11.2.GnAp.5	TGTGAGCACGGTCTACACAGCACA	GGACTACNVGGGTWTCTAAT	32	F11.2	FACS	Human	NA	Case	F11	NA	51019	P2	B05	NA	Customer Extracted	Q5	11.73	NA	11.73	2.6	2.6	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	CTACACAGCACA	TGTGAGCACGGT	IgA+IgG-	5A	run1	Y	NA	NA	000000000-CD29D
I.11.2.GnMp.5	TGTGAGCACGGTCGCATTTGGATG	GGACTACNVGGGTWTCTAAT	29	F11.2	FACS	Human	NA	Case	F11	NA	51019	P2	G04	NA	Customer Extracted	Q5	17.95	NA	17.95	1.7	1.7	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	CGCATTTGGATG	TGTGAGCACGGT	IgM+IgG-	5A	run1	Y	NA	NA	000000000-CD29D
I.11.2.GpAn.5	TGTGAGCACGGTATAACATGTGCG	GGACTACNVGGGTWTCTAAT	30	F11.2	FACS	Human	NA	Case	F11	NA	51019	P2	H04	NA	Customer Extracted	Q5	15.83	NA	15.83	1.9	1.9	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	ATAACATGTGCG	TGTGAGCACGGT	IgG+IgA-	5A	run1	Y	NA	NA	000000000-CD29D
I.11.2.GpAp.5	TGTGAGCACGGTCTTGAGAAATCG	GGACTACNVGGGTWTCTAAT	31	F11.2	FACS	Human	NA	Case	F11	NA	51019	P2	A05	NA	Customer Extracted	Q5	10.72	NA	10.72	2.8	2.8	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	CTTGAGAAATCG	TGTGAGCACGGT	IgG+IgA+	5A	run1	Y	NA	NA	000000000-CD29D
I.11.2.GpMp.5	TGTGAGCACGGTGTAGGTGCTTAC	GGACTACNVGGGTWTCTAAT	28	F11.2	FACS	Human	NA	Case	F11	NA	51019	P2	F04	NA	Customer Extracted	Q5	14.72	NA	14.72	2	2	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	GTAGGTGCTTAC	TGTGAGCACGGT	IgG+IgM+	5A	run1	Y	NA	NA	000000000-CD29D
I.11.2.MnAp.4	TGTGAGCACGGTAACCGCATAAGT	GGACTACNVGGGTWTCTAAT	26	F11.2	FACS	Human	NA	Case	F11	NA	51019	P2	D04	NA	Customer Extracted	Q5	4.01	NA	4.01	7.5	7.5	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	AACCGCATAAGT	TGTGAGCACGGT	IgA+IgM-	4A	run1	Y	NA	NA	000000000-CD29D
I.11.2.MpAn.4	TGTGAGCACGGTGACTACCCGTTG	GGACTACNVGGGTWTCTAAT	24	F11.2	FACS	Human	NA	Case	F11	NA	51019	P2	B04	NA	Customer Extracted	Q5	7.32	NA	7.32	4.1	4.1	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	GACTACCCGTTG	TGTGAGCACGGT	IgM+IgA-	4A	run1	Y	NA	NA	000000000-CD29D
I.11.2.MpAp.4	TGTGAGCACGGTGCGTTGCAAACT	GGACTACNVGGGTWTCTAAT	25	F11.2	FACS	Human	NA	Case	F11	NA	51019	P2	C04	NA	Customer Extracted	Q5	11.31	NA	11.31	2.7	2.7	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	GCGTTGCAAACT	TGTGAGCACGGT	IgM+IgA+	4A	run1	Y	NA	NA	000000000-CD29D
I.11.2.Neg.4	TGTGAGCACGGTGCCGTCTCGTAA	GGACTACNVGGGTWTCTAAT	23	F11.2	FACS	Human	NA	Case	F11	NA	51019	P2	H03	NA	Customer Extracted	Q5	4.81	NA	4.81	6.2	6.2	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	GCCGTCTCGTAA	TGTGAGCACGGT	IgA-IgM-IgG-	4A	run1	Y	NA	NA	000000000-CD29D
I.11.2.Neg.5	TGTGAGCACGGTACCTTACACCTT	GGACTACNVGGGTWTCTAAT	27	F11.2	FACS	Human	NA	Case	F11	NA	51019	P2	E04	NA	Customer Extracted	Q5	9.74	NA	9.74	3.1	3.1	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	ACCTTACACCTT	TGTGAGCACGGT	IgA-IgM-IgG-	5A	run1	Y	NA	NA	000000000-CD29D
I.14.1.GnMp.5	TGTGAGCACGGTATTATCGTCCCT	GGACTACNVGGGTWTCTAAT	38	F14.1	FACS	Human	NA	Case	F14	NA	42519	P2	H05	NA	Customer Extracted	Q5	17.78	NA	17.78	1.7	1.7	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	ATTATCGTCCCT	TGTGAGCACGGT	IgM+IgG-	5A	run1	Y	NA	NA	000000000-CD29D
I.14.1.GpMn.5	TGTGAGCACGGTAGACATACCGTA	GGACTACNVGGGTWTCTAAT	36	F14.1	FACS	Human	NA	Case	F14	NA	42519	P2	F05	NA	Customer Extracted	Q5	24.19	NA	24.19	1.2	1.2	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	AGACATACCGTA	TGTGAGCACGGT	IgG+IgM-	5A	run2	Y	NA	NA	000000000-CD29D
I.14.1.GpMp.5	TGTGAGCACGGTGATCCTCATGCG	GGACTACNVGGGTWTCTAAT	37	F14.1	FACS	Human	NA	Case	F14	NA	42519	P2	G05	NA	Customer Extracted	Q5	20.32	NA	20.32	1.5	1.5	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	GATCCTCATGCG	TGTGAGCACGGT	IgG+IgM+	5A	run2	Y	NA	NA	000000000-CD29D
I.14.1.MpAn.4	TGTGAGCACGGTTCTGAGGTTGCC	GGACTACNVGGGTWTCTAAT	34	F14.1	FACS	Human	NA	Case	F14	NA	42519	P2	D05	NA	Customer Extracted	Q5	17.65	NA	17.65	1.7	1.7	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	TCTGAGGTTGCC	TGTGAGCACGGT	IgM+IgA-	4A	run2	Y	NA	NA	000000000-CD29D
I.14.1.Neg.4	TGTGAGCACGGTGAAATGCTACGT	GGACTACNVGGGTWTCTAAT	33	F14.1	FACS	Human	NA	Case	F14	NA	42519	P2	C05	NA	Customer Extracted	Q5	27.59	NA	27.59	1.1	1.1	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	GAAATGCTACGT	TGTGAGCACGGT	IgA-IgM-IgG-	4A	run2	Y	NA	NA	000000000-CD29D
I.14.1.Neg.5	TGTGAGCACGGTGATCATTCTCTC	GGACTACNVGGGTWTCTAAT	35	F14.1	FACS	Human	NA	Case	F14	NA	42519	P2	E05	NA	Customer Extracted	Q5	14.29	NA	14.29	2.1	2.1	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	GATCATTCTCTC	TGTGAGCACGGT	IgA-IgM-IgG-	5A	run2	Y	NA	NA	000000000-CD29D
I.14.2.GnAp.5	TGTGAGCACGGTGACTGACTCGTC	GGACTACNVGGGTWTCTAAT	49	F14.2	FACS	Human	NA	Control	F14	NA	42519	P2	C07	NA	Customer Extracted	Q5	9.72	NA	9.72	3.1	3.1	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	GACTGACTCGTC	TGTGAGCACGGT	IgA+IgG-	5A	run2	Y	NA	NA	000000000-CD29D
I.14.2.GnMp.5	TGTGAGCACGGTTCCAACTGCAGA	GGACTACNVGGGTWTCTAAT	46	F14.2	FACS	Human	NA	Control	F14	NA	42519	P2	H06	NA	Customer Extracted	Q5	14.53	NA	14.53	2.1	2.1	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	TCCAACTGCAGA	TGTGAGCACGGT	IgM+IgG-	5A	run2	Y	NA	NA	000000000-CD29D
I.14.2.GpAn.5	TGTGAGCACGGTTAAAGACCCGTA	GGACTACNVGGGTWTCTAAT	47	F14.2	FACS	Human	NA	Control	F14	NA	42519	P2	A07	NA	Customer Extracted	Q5	1.1	NA	1.1	27.3	27.3	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	TAAAGACCCGTA	TGTGAGCACGGT	IgG+IgA-	5A	run2	Y	NA	NA	000000000-CD29D
I.14.2.GpAp.5	TGTGAGCACGGTTGTATCTTCACC	GGACTACNVGGGTWTCTAAT	48	F14.2	FACS	Human	NA	Control	F14	NA	42519	P2	B07	NA	Customer Extracted	Q5	20.2	NA	20.2	1.5	1.5	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	TGTATCTTCACC	TGTGAGCACGGT	IgG+IgA+	5A	run2	Y	NA	NA	000000000-CD29D
I.14.2.GpMn.5	TGTGAGCACGGTGCATTCGGCGTT	GGACTACNVGGGTWTCTAAT	44	F14.2	FACS	Human	NA	Control	F14	NA	42519	P2	F06	NA	Customer Extracted	Q5	18.25	NA	18.25	1.6	1.6	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	GCATTCGGCGTT	TGTGAGCACGGT	IgG+IgM-	5A	run2	Y	NA	NA	000000000-CD29D
I.14.2.GpMp.5	TGTGAGCACGGTCGCCATTGTGCA	GGACTACNVGGGTWTCTAAT	45	F14.2	FACS	Human	NA	Control	F14	NA	42519	P2	G06	NA	Customer Extracted	Q5	20.74	NA	20.74	1.4	1.4	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	CGCCATTGTGCA	TGTGAGCACGGT	IgG+IgM+	5A	run2	Y	NA	NA	000000000-CD29D
I.14.2.MnAp.4	TGTGAGCACGGTCGATGTGTGGTT	GGACTACNVGGGTWTCTAAT	42	F14.2	FACS	Human	NA	Control	F14	NA	42519	P2	D06	NA	Customer Extracted	Q5	8.34	NA	8.34	3.6	3.6	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	CGATGTGTGGTT	TGTGAGCACGGT	IgA+IgM-	4A	run2	Y	NA	NA	000000000-CD29D
I.14.2.MpAn.4	TGTGAGCACGGTAGCTCTAGAAAC	GGACTACNVGGGTWTCTAAT	40	F14.2	FACS	Human	NA	Control	F14	NA	42519	P2	B06	NA	Customer Extracted	Q5	14.94	NA	14.94	2	2	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	AGCTCTAGAAAC	TGTGAGCACGGT	IgM+IgA-	4A	run2	Y	NA	NA	000000000-CD29D
I.14.2.MpAp.4	TGTGAGCACGGTTCCATCGACGTG	GGACTACNVGGGTWTCTAAT	41	F14.2	FACS	Human	NA	Control	F14	NA	42519	P2	C06	NA	Customer Extracted	Q5	20.69	NA	20.69	1.4	1.4	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	TCCATCGACGTG	TGTGAGCACGGT	IgM+IgA+	4A	run2	Y	NA	NA	000000000-CD29D
I.14.2.Neg.4	TGTGAGCACGGTCCAGACCGCTAT	GGACTACNVGGGTWTCTAAT	39	F14.2	FACS	Human	NA	Control	F14	NA	42519	P2	A06	NA	Customer Extracted	Q5	12.89	NA	12.89	2.3	2.3	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	CCAGACCGCTAT	TGTGAGCACGGT	IgA-IgM-IgG-	4A	run2	Y	NA	NA	000000000-CD29D
I.14.2.Neg.5	TGTGAGCACGGTGCGAAGTTGGGA	GGACTACNVGGGTWTCTAAT	43	F14.2	FACS	Human	NA	Control	F14	NA	42519	P2	E06	NA	Customer Extracted	Q5	29.29	NA	29.29	1	1	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	GCGAAGTTGGGA	TGTGAGCACGGT	IgA-IgM-IgG-	5A	run2	Y	NA	NA	000000000-CD29D
I.33.1.GnMp.5	TGTGAGCACGGTCGCACTACGCAT	GGACTACNVGGGTWTCTAAT	55	F33.1	FACS	Human	NA	Control	F33	NA	42519	P2	A08	NA	Customer Extracted	Q5	18.61	NA	18.61	1.6	1.6	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	CGCACTACGCAT	TGTGAGCACGGT	IgM+IgG-	5A	run2	Y	NA	NA	000000000-CD29D
I.33.1.GpMn.5	TGTGAGCACGGTTAAGGCATCGCT	GGACTACNVGGGTWTCTAAT	53	F33.1	FACS	Human	NA	Control	F33	NA	42519	P2	G07	NA	Customer Extracted	Q5	16.69	NA	16.69	1.8	1.8	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	TAAGGCATCGCT	TGTGAGCACGGT	IgG+IgM-	5A	run2	Y	NA	NA	000000000-CD29D
I.33.1.GpMp.5	TGTGAGCACGGTACCCATACAGCC	GGACTACNVGGGTWTCTAAT	54	F33.1	FACS	Human	NA	Control	F33	NA	42519	P2	H07	NA	Customer Extracted	Q5	4.01	NA	4.01	7.5	7.5	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	ACCCATACAGCC	TGTGAGCACGGT	IgG+IgM+	5A	run2	Y	NA	NA	000000000-CD29D
I.33.1.MpAn.4	TGTGAGCACGGTGACGCACTAACT	GGACTACNVGGGTWTCTAAT	51	F33.1	FACS	Human	NA	Control	F33	NA	42519	P2	E07	NA	Customer Extracted	Q5	13.36	NA	13.36	2.2	2.2	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	GACGCACTAACT	TGTGAGCACGGT	IgM+IgA-	4A	run2	Y	NA	NA	000000000-CD29D
I.33.1.Neg.4	TGTGAGCACGGTTCGTGGATAGCT	GGACTACNVGGGTWTCTAAT	50	F33.1	FACS	Human	NA	Control	F33	NA	42519	P2	D07	NA	Customer Extracted	Q5	12.16	NA	12.16	2.5	2.5	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	TCGTGGATAGCT	TGTGAGCACGGT	IgA-IgM-IgG-	4A	run2	Y	NA	NA	000000000-CD29D
I.33.1.Neg.5	TGTGAGCACGGTGGCGATTTACGT	GGACTACNVGGGTWTCTAAT	52	F33.1	FACS	Human	NA	Control	F33	NA	42519	P2	F07	NA	Customer Extracted	Q5	13.84	NA	13.84	2.2	2.2	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	GGCGATTTACGT	TGTGAGCACGGT	IgA-IgM-IgG-	5A	run2	Y	NA	NA	000000000-CD29D
I.33.2.GnAp.5	TGTGAGCACGGTGTACTGAAGATC	GGACTACNVGGGTWTCTAAT	65	F33.2	FACS	Human	NA	Control	F33	NA	42519	P2	D09	NA	Customer Extracted	Q5	11.43	NA	11.43	2.6	2.6	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	GTACTGAAGATC	TGTGAGCACGGT	IgA+IgG-	5A	run2	Y	NA	NA	000000000-CD29D
I.33.2.GnMp.5	TGTGAGCACGGTCTCTTCTGATCA	GGACTACNVGGGTWTCTAAT	62	F33.2	FACS	Human	NA	Control	F33	NA	42519	P2	H08	NA	Customer Extracted	Q5	12.97	NA	12.97	2.3	2.3	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	CTCTTCTGATCA	TGTGAGCACGGT	IgM+IgG-	5A	run2	Y	NA	NA	000000000-CD29D
I.33.2.GpAn.5	TGTGAGCACGGTATGCTAACCACG	GGACTACNVGGGTWTCTAAT	63	F33.2	FACS	Human	NA	Control	F33	NA	42519	P2	A09	NA	Customer Extracted	Q5	12.33	NA	12.33	2.4	2.4	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	ATGCTAACCACG	TGTGAGCACGGT	IgG+IgA-	5A	run2	Y	NA	NA	000000000-CD29D
I.33.2.GpAp.5	TGTGAGCACGGTACCAATCTCGGC	GGACTACNVGGGTWTCTAAT	64	F33.2	FACS	Human	NA	Control	F33	NA	42519	P2	B09	NA	Customer Extracted	Q5	10.32	NA	10.32	2.9	2.9	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	ACCAATCTCGGC	TGTGAGCACGGT	IgG+IgA+	5A	run2	Y	NA	NA	000000000-CD29D
I.33.2.GpMp.5	TGTGAGCACGGTCTACTTACATCC	GGACTACNVGGGTWTCTAAT	61	F33.2	FACS	Human	NA	Control	F33	NA	42519	P2	G08	NA	Customer Extracted	Q5	12.07	NA	12.07	2.5	2.5	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	CTACTTACATCC	TGTGAGCACGGT	IgG+IgM+	5A	run2	Y	NA	NA	000000000-CD29D
I.33.2.MnAp.4	TGTGAGCACGGTGGCATGTTATCG	GGACTACNVGGGTWTCTAAT	59	F33.2	FACS	Human	NA	Control	F33	NA	42519	P2	E08	NA	Customer Extracted	Q5	12.41	NA	12.41	2.4	2.4	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	GGCATGTTATCG	TGTGAGCACGGT	IgA+IgM-	4A	run2	Y	NA	NA	000000000-CD29D
I.33.2.MpAn.4	TGTGAGCACGGTCTACGAAAGCCT	GGACTACNVGGGTWTCTAAT	57	F33.2	FACS	Human	NA	Control	F33	NA	42519	P2	C08	NA	Customer Extracted	Q5	4.95	NA	4.95	6.1	6.1	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	CTACGAAAGCCT	TGTGAGCACGGT	IgM+IgA-	4A	run2	Y	NA	NA	000000000-CD29D
I.33.2.MpAp.4	TGTGAGCACGGTATAATTGCCGAG	GGACTACNVGGGTWTCTAAT	58	F33.2	FACS	Human	NA	Control	F33	NA	42519	P2	D08	NA	Customer Extracted	Q5	11.61	NA	11.61	2.6	2.6	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	ATAATTGCCGAG	TGTGAGCACGGT	IgM+IgA+	4A	run2	Y	NA	NA	000000000-CD29D
I.33.2.Neg.4	TGTGAGCACGGTCAGTCGTTAAGA	GGACTACNVGGGTWTCTAAT	56	F33.2	FACS	Human	NA	Control	F33	NA	42519	P2	B08	NA	Customer Extracted	Q5	13.91	NA	13.91	2.2	2.2	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	CAGTCGTTAAGA	TGTGAGCACGGT	IgA-IgM-IgG-	4A	run2	Y	NA	NA	000000000-CD29D
I.33.2.Neg.5	TGTGAGCACGGTAGGCACAGTAGG	GGACTACNVGGGTWTCTAAT	60	F33.2	FACS	Human	NA	Control	F33	NA	42519	P2	F08	NA	Customer Extracted	Q5	13.31	NA	13.31	2.3	2.3	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	AGGCACAGTAGG	TGTGAGCACGGT	IgA-IgM-IgG-	5A	run2	Y	NA	NA	000000000-CD29D
I.36.1.GnMp.5	TGTGAGCACGGTTGTTAAGCAGCA	GGACTACNVGGGTWTCTAAT	71	F36.1	FACS	Human	NA	Case	F36	NA	52219	P2	B10	NA	Customer Extracted	Q5	21.45	NA	21.45	1.4	1.4	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	TGTTAAGCAGCA	TGTGAGCACGGT	IgM+IgG-	5A	run3	Y	NA	NA	000000000-CD29D
I.36.1.GpMn.5	TGTGAGCACGGTGAGATCGCCTAT	GGACTACNVGGGTWTCTAAT	69	F36.1	FACS	Human	NA	Case	F36	NA	52219	P2	H09	NA	Customer Extracted	Q5	15.28	NA	15.28	2	2	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	GAGATCGCCTAT	TGTGAGCACGGT	IgG+IgM-	5A	run3	Y	NA	NA	000000000-CD29D
I.36.1.GpMp.5	TGTGAGCACGGTTGTACATCGCCG	GGACTACNVGGGTWTCTAAT	70	F36.1	FACS	Human	NA	Case	F36	NA	52219	P2	A10	NA	Customer Extracted	Q5	12.49	NA	12.49	2.4	2.4	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	TGTACATCGCCG	TGTGAGCACGGT	IgG+IgM+	5A	run3	Y	NA	NA	000000000-CD29D
I.36.1.MpAn.4	TGTGAGCACGGTAACTGCGATATG	GGACTACNVGGGTWTCTAAT	67	F36.1	FACS	Human	NA	Case	F36	NA	52219	P2	F09	NA	Customer Extracted	Q5	16.48	NA	16.48	1.8	1.8	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	AACTGCGATATG	TGTGAGCACGGT	IgM+IgA-	4A	run3	Y	NA	NA	000000000-CD29D
I.36.1.Neg.4	TGTGAGCACGGTTCGCCGTGTACA	GGACTACNVGGGTWTCTAAT	66	F36.1	FACS	Human	NA	Case	F36	NA	52219	P2	E09	NA	Customer Extracted	Q5	20.56	NA	20.56	1.5	1.5	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	TCGCCGTGTACA	TGTGAGCACGGT	IgA-IgM-IgG-	4A	run3	Y	NA	NA	000000000-CD29D
I.36.1.Neg.5	TGTGAGCACGGTCTTCCAACTCAT	GGACTACNVGGGTWTCTAAT	68	F36.1	FACS	Human	NA	Case	F36	NA	52219	P2	G09	NA	Customer Extracted	Q5	12.02	NA	12.02	2.5	2.5	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	CTTCCAACTCAT	TGTGAGCACGGT	IgA-IgM-IgG-	5A	run3	Y	NA	NA	000000000-CD29D
I.36.2.GnAp.5	TGTGAGCACGGTCTTCGCGGATGT	GGACTACNVGGGTWTCTAAT	80	F36.2	FACS	Human	NA	Control	F36	NA	52219	P2	C11	NA	Customer Extracted	Q5	12.39	NA	12.39	2.4	2.4	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	CTTCGCGGATGT	TGTGAGCACGGT	IgA+IgG-	5A	run3	Y	NA	NA	000000000-CD29D
I.36.2.GnMp.5	TGTGAGCACGGTCGGAGTAATCCT	GGACTACNVGGGTWTCTAAT	78	F36.2	FACS	Human	NA	Control	F36	NA	52219	P2	A11	NA	Customer Extracted	Q5	13.45	NA	13.45	2.2	2.2	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	CGGAGTAATCCT	TGTGAGCACGGT	IgM+IgG-	5A	run3	Y	NA	NA	000000000-CD29D
I.36.2.GpAp.5	TGTGAGCACGGTCTGTGTCCATGG	GGACTACNVGGGTWTCTAAT	79	F36.2	FACS	Human	NA	Control	F36	NA	52219	P2	B11	NA	Customer Extracted	Q5	14.33	NA	14.33	2.1	2.1	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	CTGTGTCCATGG	TGTGAGCACGGT	IgG+IgA+	5A	run3	Y	NA	NA	000000000-CD29D
I.36.2.GpMp.5	TGTGAGCACGGTAATAGCATGTCG	GGACTACNVGGGTWTCTAAT	77	F36.2	FACS	Human	NA	Control	F36	NA	52219	P2	H10	NA	Customer Extracted	Q5	25.8	NA	25.8	1.2	1.2	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	AATAGCATGTCG	TGTGAGCACGGT	IgG+IgM+	5A	run3	Y	NA	NA	000000000-CD29D
I.36.2.MnAp.4	TGTGAGCACGGTCGAAACTACGTA	GGACTACNVGGGTWTCTAAT	75	F36.2	FACS	Human	NA	Control	F36	NA	52219	P2	F10	NA	Customer Extracted	Q5	25.94	NA	25.94	1.2	1.2	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	CGAAACTACGTA	TGTGAGCACGGT	IgA+IgM-	4A	run3	Y	NA	NA	000000000-CD29D
I.36.2.MpAn.4	TGTGAGCACGGTACTTTGCTTTGC	GGACTACNVGGGTWTCTAAT	73	F36.2	FACS	Human	NA	Control	F36	NA	52219	P2	D10	NA	Customer Extracted	Q5	13.81	NA	13.81	2.2	2.2	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	ACTTTGCTTTGC	TGTGAGCACGGT	IgM+IgA-	4A	run3	Y	NA	NA	000000000-CD29D
I.36.2.MpAp.4	TGTGAGCACGGTCAAAGCGGTATT	GGACTACNVGGGTWTCTAAT	74	F36.2	FACS	Human	NA	Control	F36	NA	52219	P2	E10	NA	Customer Extracted	Q5	13.42	NA	13.42	2.2	2.2	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	CAAAGCGGTATT	TGTGAGCACGGT	IgM+IgA+	4A	run3	Y	NA	NA	000000000-CD29D
I.36.2.Neg.4	TGTGAGCACGGTACGGCGTTATGT	GGACTACNVGGGTWTCTAAT	72	F36.2	FACS	Human	NA	Control	F36	NA	52219	P2	C10	NA	Customer Extracted	Q5	9.13	NA	9.13	3.3	3.3	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	ACGGCGTTATGT	TGTGAGCACGGT	IgA-IgM-IgG-	4A	run3	Y	NA	NA	000000000-CD29D
I.36.2.Neg.5	TGTGAGCACGGTGAGGACCAGCAA	GGACTACNVGGGTWTCTAAT	76	F36.2	FACS	Human	NA	Control	F36	NA	52219	P2	G10	NA	Customer Extracted	Q5	19.56	NA	19.56	1.5	1.5	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	GAGGACCAGCAA	TGTGAGCACGGT	IgA-IgM-IgG-	5A	run3	Y	NA	NA	000000000-CD29D
I.46.1.GnMp.5	TGTGAGCACGGTTAATGCCCAGGT	GGACTACNVGGGTWTCTAAT	86	F46.1	FACS	Human	NA	Case	F46	NA	51019	P2	A12	NA	Customer Extracted	Q5	6.25	NA	6.25	4.8	4.8	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	TAATGCCCAGGT	TGTGAGCACGGT	IgM+IgG-	5A	run3	Y	NA	NA	000000000-CD29D
I.46.1.GpMn.5	TGTGAGCACGGTGTTTCCGTGGTG	GGACTACNVGGGTWTCTAAT	84	F46.1	FACS	Human	NA	Case	F46	NA	51019	P2	G11	NA	Customer Extracted	Q5	14.86	NA	14.86	2	2	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	GTTTCCGTGGTG	TGTGAGCACGGT	IgG+IgM-	5A	run3	Y	NA	NA	000000000-CD29D
I.46.1.GpMp.5	TGTGAGCACGGTAGGAACCAGACG	GGACTACNVGGGTWTCTAAT	85	F46.1	FACS	Human	NA	Case	F46	NA	51019	P2	H11	NA	Customer Extracted	Q5	12.14	NA	12.14	2.5	2.5	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	AGGAACCAGACG	TGTGAGCACGGT	IgG+IgM+	5A	run3	Y	NA	NA	000000000-CD29D
I.46.1.MpAn.4	TGTGAGCACGGTTGTGTAGCCATG	GGACTACNVGGGTWTCTAAT	82	F46.1	FACS	Human	NA	Case	F46	NA	51019	P2	E11	NA	Customer Extracted	Q5	18.24	NA	18.24	1.6	1.6	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	TGTGTAGCCATG	TGTGAGCACGGT	IgM+IgA-	4A	run3	Y	NA	NA	000000000-CD29D
I.46.1.Neg.4	TGTGAGCACGGTATAGGCTGTAGT	GGACTACNVGGGTWTCTAAT	81	F46.1	FACS	Human	NA	Case	F46	NA	51019	P2	D11	NA	Customer Extracted	Q5	8.86	NA	8.86	3.4	3.4	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	ATAGGCTGTAGT	TGTGAGCACGGT	IgA-IgM-IgG-	4A	run3	Y	NA	NA	000000000-CD29D
I.46.1.Neg.5	TGTGAGCACGGTAAGGGCGCTGAA	GGACTACNVGGGTWTCTAAT	83	F46.1	FACS	Human	NA	Case	F46	NA	51019	P2	F11	NA	Customer Extracted	Q5	11.44	NA	11.44	2.6	2.6	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	AAGGGCGCTGAA	TGTGAGCACGGT	IgA-IgM-IgG-	5A	run3	Y	NA	NA	000000000-CD29D
I.46.2.GnAp.5	CTGGAAATCTGCCTTAGGCATGTG	GGACTACNVGGGTWTCTAAT	97	F46.2	FACS	Human	NA	Control	F46	NA	51019	P3	D01	NA	Customer Extracted	Q5	13.39	NA	13.39	2.2	2.2	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	CTTAGGCATGTG	CTGGAAATCTGC	IgA+IgG-	5A	run3	Y	NA	NA	000000000-CD29D
I.46.2.GnMp.5	CTGGAAATCTGCACTCTAGCCGGT	GGACTACNVGGGTWTCTAAT	94	F46.2	FACS	Human	NA	Control	F46	NA	51019	P3	A01	NA	Customer Extracted	Q5	1.21	NA	1.21	24.8	24.8	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	ACTCTAGCCGGT	CTGGAAATCTGC	IgM+IgG-	5A	run3	Y	NA	NA	000000000-CD29D
I.46.2.GpAn.5	CTGGAAATCTGCCGATAGGCCTTA	GGACTACNVGGGTWTCTAAT	95	F46.2	FACS	Human	NA	Control	F46	NA	51019	P3	B01	NA	Customer Extracted	Q5	10.94	NA	10.94	2.7	2.7	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	CGATAGGCCTTA	CTGGAAATCTGC	IgG+IgA-	5A	run3	Y	NA	NA	000000000-CD29D
I.46.2.GpAp.5	CTGGAAATCTGCAATGACCTCGTG	GGACTACNVGGGTWTCTAAT	96	F46.2	FACS	Human	NA	Control	F46	NA	51019	P3	C01	NA	Customer Extracted	Q5	8.73	NA	8.73	3.4	3.4	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	AATGACCTCGTG	CTGGAAATCTGC	IgG+IgA+	5A	run3	Y	NA	NA	000000000-CD29D
I.46.2.GpMp.5	TGTGAGCACGGTCTTGACGAGGTT	GGACTACNVGGGTWTCTAAT	93	F46.2	FACS	Human	NA	Control	F46	NA	51019	P2	H12	NA	Customer Extracted	Q5	13.32	NA	13.32	2.3	2.3	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	CTTGACGAGGTT	TGTGAGCACGGT	IgG+IgM+	5A	run3	Y	NA	NA	000000000-CD29D
I.46.2.MnAp.4	TGTGAGCACGGTGCTGTGATTCGA	GGACTACNVGGGTWTCTAAT	90	F46.2	FACS	Human	NA	Control	F46	NA	51019	P2	F12	NA	Customer Extracted	Q5	11.78	NA	11.78	2.5	2.5	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	GCTGTGATTCGA	TGTGAGCACGGT	IgA+IgM-	4A	run3	Y	NA	NA	000000000-CD29D
I.46.2.MpAn.4	TGTGAGCACGGTCCACATTGGGTC	GGACTACNVGGGTWTCTAAT	88	F46.2	FACS	Human	NA	Control	F46	NA	51019	P2	C12	NA	Customer Extracted	Q5	16.54	NA	16.54	1.8	1.8	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	CCACATTGGGTC	TGTGAGCACGGT	IgM+IgA-	4A	run3	Y	NA	NA	000000000-CD29D
I.46.2.MpAp.4	TGTGAGCACGGTTCAGTCAGATGA	GGACTACNVGGGTWTCTAAT	89	F46.2	FACS	Human	NA	Control	F46	NA	51019	P2	D12	NA	Customer Extracted	Q5	11.11	NA	11.11	2.7	2.7	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	TCAGTCAGATGA	TGTGAGCACGGT	IgM+IgA+	4A	run3	Y	NA	NA	000000000-CD29D
I.46.2.Neg.4	TGTGAGCACGGTTATGAACGTCCG	GGACTACNVGGGTWTCTAAT	87	F46.2	FACS	Human	NA	Control	F46	NA	51019	P2	B12	NA	Customer Extracted	Q5	12.29	NA	12.29	2.4	2.4	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	TATGAACGTCCG	TGTGAGCACGGT	IgA-IgM-IgG-	4A	run3	Y	NA	NA	000000000-CD29D
I.46.2.Neg.5	TGTGAGCACGGTCTAGCTATGGAC	GGACTACNVGGGTWTCTAAT	91	F46.2	FACS	Human	NA	Control	F46	NA	51019	P2	G12	NA	Customer Extracted	Q5	5.37	NA	5.37	5.6	5.6	TRUE	000000000-CD29D	20190701	Silvermen	19132	19136	CTAGCTATGGAC	TGTGAGCACGGT	IgA-IgM-IgG-	5A	run3	Y	NA	NA	000000000-CD29D
I.47.1.GnMp.5	CTGGAAATCTGCACTGACTTAAGG	GGACTACNVGGGTWTCTAAT	103	F47.1	FACS	Human	NA	Case	F47	NA	50919	P3	B02	NA	Customer Extracted	Q5	9.28	NA	9.28	3.2	3.2	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	ACTGACTTAAGG	CTGGAAATCTGC	IgM+IgG-	5A	run4	Y	NA	NA	000000000-CD29D
I.47.1.GpMn.5	CTGGAAATCTGCACGTGTAGGCTT	GGACTACNVGGGTWTCTAAT	101	F47.1	FACS	Human	NA	Case	F47	NA	50919	P3	H01	NA	Customer Extracted	Q5	7.32	NA	7.32	4.1	4.1	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	ACGTGTAGGCTT	CTGGAAATCTGC	IgG+IgM-	5A	run4	Y	NA	NA	000000000-CD29D
I.47.1.GpMp.5	CTGGAAATCTGCGGTCTCCTACAG	GGACTACNVGGGTWTCTAAT	102	F47.1	FACS	Human	NA	Case	F47	NA	50919	P3	A02	NA	Customer Extracted	Q5	9.55	NA	9.55	3.1	3.1	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	GGTCTCCTACAG	CTGGAAATCTGC	IgG+IgM+	5A	run4	Y	NA	NA	000000000-CD29D
I.47.1.MpAn.4	CTGGAAATCTGCGAGAGTCCACTT	GGACTACNVGGGTWTCTAAT	99	F47.1	FACS	Human	NA	Case	F47	NA	50919	P3	F01	NA	Customer Extracted	Q5	11.21	NA	11.21	2.7	2.7	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	GAGAGTCCACTT	CTGGAAATCTGC	IgM+IgA-	4A	run4	Y	NA	NA	000000000-CD29D
I.47.1.Neg.4	CTGGAAATCTGCCCAGATATAGCA	GGACTACNVGGGTWTCTAAT	98	F47.1	FACS	Human	NA	Case	F47	NA	50919	P3	E01	NA	Customer Extracted	Q5	5.36	NA	5.36	5.6	5.6	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	CCAGATATAGCA	CTGGAAATCTGC	IgA-IgM-IgG-	4A	run4	Y	NA	NA	000000000-CD29D
I.47.1.Neg.5	CTGGAAATCTGCGAACGGGACGTA	GGACTACNVGGGTWTCTAAT	100	F47.1	FACS	Human	NA	Case	F47	NA	50919	P3	G01	NA	Customer Extracted	Q5	8.59	NA	8.59	3.5	3.5	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	GAACGGGACGTA	CTGGAAATCTGC	IgA-IgM-IgG-	5A	run4	Y	NA	NA	000000000-CD29D
I.47.2.GnAp.5	CTGGAAATCTGCATAGCGAACTCA	GGACTACNVGGGTWTCTAAT	114	F47.2	FACS	Human	NA	Control	F47	NA	50919	P3	E03	NA	Customer Extracted	Q5	1.89	NA	1.89	15.9	15.9	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	ATAGCGAACTCA	CTGGAAATCTGC	IgA+IgG-	5A	run4	Y	NA	NA	000000000-CD29D
I.47.2.GnMp.5	CTGGAAATCTGCGATCTCTGGGTA	GGACTACNVGGGTWTCTAAT	111	F47.2	FACS	Human	NA	Control	F47	NA	50919	P3	B03	NA	Customer Extracted	Q5	7.36	NA	7.36	4.1	4.1	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	GATCTCTGGGTA	CTGGAAATCTGC	IgM+IgG-	5A	run4	Y	NA	NA	000000000-CD29D
I.47.2.GpAn.5	CTGGAAATCTGCCATCATACGGGT	GGACTACNVGGGTWTCTAAT	112	F47.2	FACS	Human	NA	Control	F47	NA	50919	P3	C03	NA	Customer Extracted	Q5	5.28	NA	5.28	5.7	5.7	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	CATCATACGGGT	CTGGAAATCTGC	IgG+IgA-	5A	run4	Y	NA	NA	000000000-CD29D
I.47.2.GpAp.5	CTGGAAATCTGCTACGGATTATGG	GGACTACNVGGGTWTCTAAT	113	F47.2	FACS	Human	NA	Control	F47	NA	50919	P3	D03	NA	Customer Extracted	Q5	11.29	NA	11.29	2.7	2.7	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	TACGGATTATGG	CTGGAAATCTGC	IgG+IgA+	5A	run4	Y	NA	NA	000000000-CD29D
I.47.2.GpMn.5	CTGGAAATCTGCGAGCGTATCCAT	GGACTACNVGGGTWTCTAAT	109	F47.2	FACS	Human	NA	Control	F47	NA	50919	P3	H02	NA	Customer Extracted	Q5	7.05	NA	7.05	4.3	4.3	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	GAGCGTATCCAT	CTGGAAATCTGC	IgG+IgM-	5A	run4	Y	NA	NA	000000000-CD29D
I.47.2.GpMp.5	CTGGAAATCTGCATGGGCGAATGG	GGACTACNVGGGTWTCTAAT	110	F47.2	FACS	Human	NA	Control	F47	NA	50919	P3	A03	NA	Customer Extracted	Q5	9.26	NA	9.26	3.2	3.2	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	ATGGGCGAATGG	CTGGAAATCTGC	IgG+IgM+	5A	run4	Y	NA	NA	000000000-CD29D
I.47.2.MnAp.4	CTGGAAATCTGCTGGCTTTCTATC	GGACTACNVGGGTWTCTAAT	107	F47.2	FACS	Human	NA	Control	F47	NA	50919	P3	F02	NA	Customer Extracted	Q5	6.94	NA	6.94	4.3	4.3	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	TGGCTTTCTATC	CTGGAAATCTGC	IgA+IgM-	4A	run4	Y	NA	NA	000000000-CD29D
I.47.2.MpAn.4	CTGGAAATCTGCTTCCTAGGCCAG	GGACTACNVGGGTWTCTAAT	105	F47.2	FACS	Human	NA	Control	F47	NA	50919	P3	D02	NA	Customer Extracted	Q5	2.2	NA	2.2	13.6	13.6	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	TTCCTAGGCCAG	CTGGAAATCTGC	IgM+IgA-	4A	run4	Y	NA	NA	000000000-CD29D
I.47.2.MpAp.4	CTGGAAATCTGCATTAAGCCTGGA	GGACTACNVGGGTWTCTAAT	106	F47.2	FACS	Human	NA	Control	F47	NA	50919	P3	E02	NA	Customer Extracted	Q5	2.95	NA	2.95	10.2	10.2	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	ATTAAGCCTGGA	CTGGAAATCTGC	IgM+IgA+	4A	run4	Y	NA	NA	000000000-CD29D
I.47.2.Neg.4	CTGGAAATCTGCGATGCTGCCGTT	GGACTACNVGGGTWTCTAAT	104	F47.2	FACS	Human	NA	Control	F47	NA	50919	P3	C02	NA	Customer Extracted	Q5	5.41	NA	5.41	5.5	5.5	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	GATGCTGCCGTT	CTGGAAATCTGC	IgA-IgM-IgG-	4A	run4	Y	NA	NA	000000000-CD29D
I.47.2.Neg.5	CTGGAAATCTGCACAGCTCAAACA	GGACTACNVGGGTWTCTAAT	108	F47.2	FACS	Human	NA	Control	F47	NA	50919	P3	G02	NA	Customer Extracted	Q5	10.03	NA	10.03	3	3	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	ACAGCTCAAACA	CTGGAAATCTGC	IgA-IgM-IgG-	5A	run4	Y	NA	NA	000000000-CD29D
I.48.1.GnMp.5	CTGGAAATCTGCACCTTACACCTT	GGACTACNVGGGTWTCTAAT	120	F48.1	FACS	Human	NA	Case	F48	NA	50119	P3	E04	NA	Customer Extracted	Q5	8.83	NA	8.83	3.4	3.4	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	ACCTTACACCTT	CTGGAAATCTGC	IgM+IgG-	5A	run4	Y	NA	NA	000000000-CD29D
I.48.1.GpMn.5	CTGGAAATCTGCGCGTTGCAAACT	GGACTACNVGGGTWTCTAAT	118	F48.1	FACS	Human	NA	Case	F48	NA	50119	P3	C04	NA	Customer Extracted	Q5	11.47	NA	11.47	2.6	2.6	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	GCGTTGCAAACT	CTGGAAATCTGC	IgG+IgM-	5A	run4	Y	NA	NA	000000000-CD29D
I.48.1.GpMp.5	CTGGAAATCTGCAACCGCATAAGT	GGACTACNVGGGTWTCTAAT	119	F48.1	FACS	Human	NA	Case	F48	NA	50119	P3	D04	NA	Customer Extracted	Q5	4.37	NA	4.37	6.9	6.9	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	AACCGCATAAGT	CTGGAAATCTGC	IgG+IgM+	5A	run4	Y	NA	NA	000000000-CD29D
I.48.1.MpAn.4	CTGGAAATCTGCGCCGTCTCGTAA	GGACTACNVGGGTWTCTAAT	116	F48.1	FACS	Human	NA	Case	F48	NA	50119	P3	H03	NA	Customer Extracted	Q5	1.94	NA	1.94	15.5	15.5	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	GCCGTCTCGTAA	CTGGAAATCTGC	IgM+IgA-	4A	run4	Y	NA	NA	000000000-CD29D
I.48.1.Neg.4	CTGGAAATCTGCTAACGCTGTGTG	GGACTACNVGGGTWTCTAAT	115	F48.1	FACS	Human	NA	Case	F48	NA	50119	P3	F03	NA	Customer Extracted	Q5	5.62	NA	5.62	5.3	5.3	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	TAACGCTGTGTG	CTGGAAATCTGC	IgA-IgM-IgG-	4A	run4	Y	NA	NA	000000000-CD29D
I.48.1.Neg.5	CTGGAAATCTGCGACTACCCGTTG	GGACTACNVGGGTWTCTAAT	117	F48.1	FACS	Human	NA	Case	F48	NA	50119	P3	B04	NA	Customer Extracted	Q5	6.9	NA	6.9	4.3	4.3	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	GACTACCCGTTG	CTGGAAATCTGC	IgA-IgM-IgG-	5A	run4	Y	NA	NA	000000000-CD29D
I.48.2.GnAp.5	CTGGAAATCTGCGATCCTCATGCG	GGACTACNVGGGTWTCTAAT	130	F48.2	FACS	Human	NA	Case	F48	NA	50119	P3	G05	NA	Customer Extracted	Q5	9.03	NA	9.03	3.3	3.3	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	GATCCTCATGCG	CTGGAAATCTGC	IgA+IgG-	5A	run4	Y	NA	NA	000000000-CD29D
I.48.2.GnMp.5	CTGGAAATCTGCTCTGAGGTTGCC	GGACTACNVGGGTWTCTAAT	127	F48.2	FACS	Human	NA	Case	F48	NA	50119	P3	D05	NA	Customer Extracted	Q5	12.44	NA	12.44	2.4	2.4	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	TCTGAGGTTGCC	CTGGAAATCTGC	IgM+IgG-	5A	run4	Y	NA	NA	000000000-CD29D
I.48.2.GpAn.5	CTGGAAATCTGCGATCATTCTCTC	GGACTACNVGGGTWTCTAAT	128	F48.2	FACS	Human	NA	Case	F48	NA	50119	P3	E05	NA	Customer Extracted	Q5	12.61	NA	12.61	2.4	2.4	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	GATCATTCTCTC	CTGGAAATCTGC	IgG+IgA-	5A	run4	Y	NA	NA	000000000-CD29D
I.48.2.GpAp.5	CTGGAAATCTGCAGACATACCGTA	GGACTACNVGGGTWTCTAAT	129	F48.2	FACS	Human	NA	Case	F48	NA	50119	P3	F05	NA	Customer Extracted	Q5	14.76	NA	14.76	2	2	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	AGACATACCGTA	CTGGAAATCTGC	IgG+IgA+	5A	run4	Y	NA	NA	000000000-CD29D
I.48.2.GpMp.5	CTGGAAATCTGCGAAATGCTACGT	GGACTACNVGGGTWTCTAAT	126	F48.2	FACS	Human	NA	Case	F48	NA	50119	P3	C05	NA	Customer Extracted	Q5	7.44	NA	7.44	4	4	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	GAAATGCTACGT	CTGGAAATCTGC	IgG+IgM+	5A	run4	Y	NA	NA	000000000-CD29D
I.48.2.MnAp.4	CTGGAAATCTGCCTTGAGAAATCG	GGACTACNVGGGTWTCTAAT	124	F48.2	FACS	Human	NA	Case	F48	NA	50119	P3	A05	NA	Customer Extracted	Q5	5.23	NA	5.23	5.7	5.7	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	CTTGAGAAATCG	CTGGAAATCTGC	IgA+IgM-	4A	run4	Y	NA	NA	000000000-CD29D
I.48.2.MpAn.4	CTGGAAATCTGCCGCATTTGGATG	GGACTACNVGGGTWTCTAAT	122	F48.2	FACS	Human	NA	Case	F48	NA	50119	P3	G04	NA	Customer Extracted	Q5	12.99	NA	12.99	2.3	2.3	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	CGCATTTGGATG	CTGGAAATCTGC	IgM+IgA-	4A	run4	Y	NA	NA	000000000-CD29D
I.48.2.MpAp.4	CTGGAAATCTGCATAACATGTGCG	GGACTACNVGGGTWTCTAAT	123	F48.2	FACS	Human	NA	Case	F48	NA	50119	P3	H04	NA	Customer Extracted	Q5	12.23	NA	12.23	2.5	2.5	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	ATAACATGTGCG	CTGGAAATCTGC	IgM+IgA+	4A	run4	Y	NA	NA	000000000-CD29D
I.48.2.Neg.4	CTGGAAATCTGCGTAGGTGCTTAC	GGACTACNVGGGTWTCTAAT	121	F48.2	FACS	Human	NA	Case	F48	NA	50119	P3	F04	NA	Customer Extracted	Q5	14.92	NA	14.92	2	2	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	GTAGGTGCTTAC	CTGGAAATCTGC	IgA-IgM-IgG-	4A	run4	Y	NA	NA	000000000-CD29D
I.48.2.Neg.5	CTGGAAATCTGCCTACACAGCACA	GGACTACNVGGGTWTCTAAT	125	F48.2	FACS	Human	NA	Case	F48	NA	50119	P3	B05	NA	Customer Extracted	Q5	11.09	NA	11.09	2.7	2.7	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	CTACACAGCACA	CTGGAAATCTGC	IgA-IgM-IgG-	5A	run4	Y	NA	NA	000000000-CD29D
I.49.1.GnMp.5	CTGGAAATCTGCGCGAAGTTGGGA	GGACTACNVGGGTWTCTAAT	136	F49.1	FACS	Human	NA	Case	F49	NA	41719	P3	E06	NA	Customer Extracted	Q5	17.67	NA	17.67	1.7	1.7	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	GCGAAGTTGGGA	CTGGAAATCTGC	IgM+IgG-	5A	run7	Y	NA	NA	000000000-CD29D
I.49.1.GpMn.5	CTGGAAATCTGCTCCATCGACGTG	GGACTACNVGGGTWTCTAAT	134	F49.1	FACS	Human	NA	Case	F49	NA	41719	P3	C06	NA	Customer Extracted	Q5	8.85	NA	8.85	3.4	3.4	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	TCCATCGACGTG	CTGGAAATCTGC	IgG+IgM-	5A	run7	Y	NA	NA	000000000-CD29D
I.49.1.GpMp.5	CTGGAAATCTGCCGATGTGTGGTT	GGACTACNVGGGTWTCTAAT	135	F49.1	FACS	Human	NA	Case	F49	NA	41719	P3	D06	NA	Customer Extracted	Q5	2.34	NA	2.34	12.8	12.8	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	CGATGTGTGGTT	CTGGAAATCTGC	IgG+IgM+	5A	run7	Y	NA	NA	000000000-CD29D
I.49.1.MpAn.4	CTGGAAATCTGCCCAGACCGCTAT	GGACTACNVGGGTWTCTAAT	132	F49.1	FACS	Human	NA	Case	F49	NA	41719	P3	A06	NA	Customer Extracted	Q5	13.27	NA	13.27	2.3	2.3	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	CCAGACCGCTAT	CTGGAAATCTGC	IgM+IgA-	4A	run7	Y	NA	NA	000000000-CD29D
I.49.1.Neg.4	CTGGAAATCTGCATTATCGTCCCT	GGACTACNVGGGTWTCTAAT	131	F49.1	FACS	Human	NA	Case	F49	NA	41719	P3	H05	NA	Customer Extracted	Q5	15.39	NA	15.39	1.9	1.9	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	ATTATCGTCCCT	CTGGAAATCTGC	IgA-IgM-IgG-	4A	run7	Y	NA	NA	000000000-CD29D
I.49.1.Neg.5	CTGGAAATCTGCAGCTCTAGAAAC	GGACTACNVGGGTWTCTAAT	133	F49.1	FACS	Human	NA	Case	F49	NA	41719	P3	B06	NA	Customer Extracted	Q5	11.05	NA	11.05	2.7	2.7	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	AGCTCTAGAAAC	CTGGAAATCTGC	IgA-IgM-IgG-	5A	run7	Y	NA	NA	000000000-CD29D
I.49.2.GnAp.5	CTGGAAATCTGCACCCATACAGCC	GGACTACNVGGGTWTCTAAT	147	F49.2	FACS	Human	NA	Control	F49	NA	41719	P3	H07	NA	Customer Extracted	Q5	3.36	NA	3.36	8.9	8.9	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	ACCCATACAGCC	CTGGAAATCTGC	IgA+IgG-	5A	run7	Y	NA	NA	000000000-CD29D
I.49.2.GnMp.5	CTGGAAATCTGCGACGCACTAACT	GGACTACNVGGGTWTCTAAT	144	F49.2	FACS	Human	NA	Control	F49	NA	41719	P3	E07	NA	Customer Extracted	Q5	22.39	NA	22.39	1.3	1.3	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	GACGCACTAACT	CTGGAAATCTGC	IgM+IgG-	5A	run7	Y	NA	NA	000000000-CD29D
I.49.2.GpAn.5	CTGGAAATCTGCGGCGATTTACGT	GGACTACNVGGGTWTCTAAT	145	F49.2	FACS	Human	NA	Control	F49	NA	41719	P3	F07	NA	Customer Extracted	Q5	15.26	NA	15.26	2	2	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	GGCGATTTACGT	CTGGAAATCTGC	IgG+IgA-	5A	run7	Y	NA	NA	000000000-CD29D
I.49.2.GpAp.5	CTGGAAATCTGCTAAGGCATCGCT	GGACTACNVGGGTWTCTAAT	146	F49.2	FACS	Human	NA	Control	F49	NA	41719	P3	G07	NA	Customer Extracted	Q5	14.1	NA	14.1	2.1	2.1	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	TAAGGCATCGCT	CTGGAAATCTGC	IgG+IgA+	5A	run7	Y	NA	NA	000000000-CD29D
I.49.2.GpMn.5	CTGGAAATCTGCGACTGACTCGTC	GGACTACNVGGGTWTCTAAT	142	F49.2	FACS	Human	NA	Control	F49	NA	41719	P3	C07	NA	Customer Extracted	Q5	8.73	NA	8.73	3.4	3.4	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	GACTGACTCGTC	CTGGAAATCTGC	IgG+IgM-	5A	run7	Y	NA	NA	000000000-CD29D
I.49.2.GpMp.5	CTGGAAATCTGCTCGTGGATAGCT	GGACTACNVGGGTWTCTAAT	143	F49.2	FACS	Human	NA	Control	F49	NA	41719	P3	D07	NA	Customer Extracted	Q5	1.27	NA	1.27	23.6	23.6	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	TCGTGGATAGCT	CTGGAAATCTGC	IgG+IgM+	5A	run7	Y	NA	NA	000000000-CD29D
I.49.2.MnAp.4	CTGGAAATCTGCTAAAGACCCGTA	GGACTACNVGGGTWTCTAAT	140	F49.2	FACS	Human	NA	Control	F49	NA	41719	P3	A07	NA	Customer Extracted	Q5	5.94	NA	5.94	5.1	5.1	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	TAAAGACCCGTA	CTGGAAATCTGC	IgA+IgM-	4A	run7	Y	NA	NA	000000000-CD29D
I.49.2.MpAn.4	CTGGAAATCTGCCGCCATTGTGCA	GGACTACNVGGGTWTCTAAT	138	F49.2	FACS	Human	NA	Control	F49	NA	41719	P3	G06	NA	Customer Extracted	Q5	18	NA	18	1.7	1.7	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	CGCCATTGTGCA	CTGGAAATCTGC	IgM+IgA-	4A	run7	Y	NA	NA	000000000-CD29D
I.49.2.MpAp.4	CTGGAAATCTGCTCCAACTGCAGA	GGACTACNVGGGTWTCTAAT	139	F49.2	FACS	Human	NA	Control	F49	NA	41719	P3	H06	NA	Customer Extracted	Q5	17.75	NA	17.75	1.7	1.7	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	TCCAACTGCAGA	CTGGAAATCTGC	IgM+IgA+	4A	run7	Y	NA	NA	000000000-CD29D
I.49.2.Neg.4	CTGGAAATCTGCGCATTCGGCGTT	GGACTACNVGGGTWTCTAAT	137	F49.2	FACS	Human	NA	Control	F49	NA	41719	P3	F06	NA	Customer Extracted	Q5	16.77	NA	16.77	1.8	1.8	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	GCATTCGGCGTT	CTGGAAATCTGC	IgA-IgM-IgG-	4A	run7	Y	NA	NA	000000000-CD29D
I.49.2.Neg.5	CTGGAAATCTGCTGTATCTTCACC	GGACTACNVGGGTWTCTAAT	141	F49.2	FACS	Human	NA	Control	F49	NA	41719	P3	B07	NA	Customer Extracted	Q5	16.77	NA	16.77	1.8	1.8	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	TGTATCTTCACC	CTGGAAATCTGC	IgA-IgM-IgG-	5A	run7	Y	NA	NA	000000000-CD29D
I.49.3.GnAp.5	CTGGAAATCTGCGTACTGAAGATC	GGACTACNVGGGTWTCTAAT	158	F49.3	FACS	Human	NA	Control	F49	NA	41819	P3	D09	NA	Customer Extracted	Q5	8.47	NA	8.47	3.5	3.5	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	GTACTGAAGATC	CTGGAAATCTGC	IgA+IgG-	5A	run7	Y	NA	NA	000000000-CD29D
I.49.3.GnMp.5	CTGGAAATCTGCCTCTTCTGATCA	GGACTACNVGGGTWTCTAAT	155	F49.3	FACS	Human	NA	Control	F49	NA	41819	P3	H08	NA	Customer Extracted	Q5	9.13	NA	9.13	3.3	3.3	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	CTCTTCTGATCA	CTGGAAATCTGC	IgM+IgG-	5A	run7	Y	NA	NA	000000000-CD29D
I.49.3.GpAn.5	CTGGAAATCTGCATGCTAACCACG	GGACTACNVGGGTWTCTAAT	156	F49.3	FACS	Human	NA	Control	F49	NA	41819	P3	A09	NA	Customer Extracted	Q5	13.9	NA	13.9	2.2	2.2	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	ATGCTAACCACG	CTGGAAATCTGC	IgG+IgA-	5A	run7	Y	NA	NA	000000000-CD29D
I.49.3.GpAp.5	CTGGAAATCTGCACCAATCTCGGC	GGACTACNVGGGTWTCTAAT	157	F49.3	FACS	Human	NA	Control	F49	NA	41819	P3	B09	NA	Customer Extracted	Q5	13.56	NA	13.56	2.2	2.2	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	ACCAATCTCGGC	CTGGAAATCTGC	IgG+IgA+	5A	run7	Y	NA	NA	000000000-CD29D
I.49.3.GpMn.5	CTGGAAATCTGCAGGCACAGTAGG	GGACTACNVGGGTWTCTAAT	153	F49.3	FACS	Human	NA	Control	F49	NA	41819	P3	F08	NA	Customer Extracted	Q5	1.51	NA	1.51	19.9	19.9	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	AGGCACAGTAGG	CTGGAAATCTGC	IgG+IgM-	5A	run7	Y	NA	NA	000000000-CD29D
I.49.3.GpMp.5	CTGGAAATCTGCCTACTTACATCC	GGACTACNVGGGTWTCTAAT	154	F49.3	FACS	Human	NA	Control	F49	NA	41819	P3	G08	NA	Customer Extracted	Q5	7.93	NA	7.93	3.8	3.8	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	CTACTTACATCC	CTGGAAATCTGC	IgG+IgM+	5A	run7	Y	NA	NA	000000000-CD29D
I.49.3.MnAp.4	CTGGAAATCTGCATAATTGCCGAG	GGACTACNVGGGTWTCTAAT	151	F49.3	FACS	Human	NA	Control	F49	NA	41819	P3	D08	NA	Customer Extracted	Q5	15.62	NA	15.62	1.9	1.9	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	ATAATTGCCGAG	CTGGAAATCTGC	IgA+IgM-	4A	run7	Y	NA	NA	000000000-CD29D
I.49.3.MpAn.4	CTGGAAATCTGCCAGTCGTTAAGA	GGACTACNVGGGTWTCTAAT	149	F49.3	FACS	Human	NA	Control	F49	NA	41819	P3	B08	NA	Customer Extracted	Q5	14.13	NA	14.13	2.1	2.1	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	CAGTCGTTAAGA	CTGGAAATCTGC	IgM+IgA-	4A	run7	Y	NA	NA	000000000-CD29D
I.49.3.MpAp.4	CTGGAAATCTGCCTACGAAAGCCT	GGACTACNVGGGTWTCTAAT	150	F49.3	FACS	Human	NA	Control	F49	NA	41819	P3	C08	NA	Customer Extracted	Q5	7.13	NA	7.13	4.2	4.2	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	CTACGAAAGCCT	CTGGAAATCTGC	IgM+IgA+	4A	run7	Y	NA	NA	000000000-CD29D
I.49.3.Neg.4	CTGGAAATCTGCCGCACTACGCAT	GGACTACNVGGGTWTCTAAT	148	F49.3	FACS	Human	NA	Control	F49	NA	41819	P3	A08	NA	Customer Extracted	Q5	9.08	NA	9.08	3.3	3.3	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	CGCACTACGCAT	CTGGAAATCTGC	IgA-IgM-IgG-	4A	run7	Y	NA	NA	000000000-CD29D
I.49.3.Neg.5	CTGGAAATCTGCGGCATGTTATCG	GGACTACNVGGGTWTCTAAT	152	F49.3	FACS	Human	NA	Control	F49	NA	41819	P3	E08	NA	Customer Extracted	Q5	12.48	NA	12.48	2.4	2.4	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	GGCATGTTATCG	CTGGAAATCTGC	IgA-IgM-IgG-	5A	run7	Y	NA	NA	000000000-CD29D
I.50.1.GnAp.5	CTGGAAATCTGCCGAAACTACGTA	GGACTACNVGGGTWTCTAAT	168	F50.1	FACS	Human	NA	Case	F50	NA	50219	P3	F10	NA	Customer Extracted	Q5	3.81	NA	3.81	7.9	7.9	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	CGAAACTACGTA	CTGGAAATCTGC	IgA+IgG-	5A	run6	Y	NA	NA	000000000-CD29D
I.50.1.GnMp.5	CTGGAAATCTGCACGGCGTTATGT	GGACTACNVGGGTWTCTAAT	165	F50.1	FACS	Human	NA	Case	F50	NA	50219	P3	C10	NA	Customer Extracted	Q5	3.4	NA	3.4	8.8	8.8	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	ACGGCGTTATGT	CTGGAAATCTGC	IgM+IgG-	5A	run6	Y	NA	NA	000000000-CD29D
I.50.1.GpAn.5	CTGGAAATCTGCACTTTGCTTTGC	GGACTACNVGGGTWTCTAAT	166	F50.1	FACS	Human	NA	Case	F50	NA	50219	P3	D10	NA	Customer Extracted	Q5	6.91	NA	6.91	4.3	4.3	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	ACTTTGCTTTGC	CTGGAAATCTGC	IgG+IgA-	5A	run6	Y	NA	NA	000000000-CD29D
I.50.1.GpAp.5	CTGGAAATCTGCCAAAGCGGTATT	GGACTACNVGGGTWTCTAAT	167	F50.1	FACS	Human	NA	Case	F50	NA	50219	P3	E10	NA	Customer Extracted	Q5	3.3	NA	3.3	9.1	9.1	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	CAAAGCGGTATT	CTGGAAATCTGC	IgG+IgA+	5A	run6	Y	NA	NA	000000000-CD29D
I.50.1.GpMp.5	CTGGAAATCTGCTGTTAAGCAGCA	GGACTACNVGGGTWTCTAAT	164	F50.1	FACS	Human	NA	Case	F50	NA	50219	P3	B10	NA	Customer Extracted	Q5	5.68	NA	5.68	5.3	5.3	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	TGTTAAGCAGCA	CTGGAAATCTGC	IgG+IgM+	5A	run6	Y	NA	NA	000000000-CD29D
I.50.1.MnAp.4	CTGGAAATCTGCGAGATCGCCTAT	GGACTACNVGGGTWTCTAAT	162	F50.1	FACS	Human	NA	Case	F50	NA	50219	P3	H09	NA	Customer Extracted	Q5	3.42	NA	3.42	8.8	8.8	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	GAGATCGCCTAT	CTGGAAATCTGC	IgA+IgM-	4A	run6	Y	NA	NA	000000000-CD29D
I.50.1.MpAn.4	CTGGAAATCTGCAACTGCGATATG	GGACTACNVGGGTWTCTAAT	160	F50.1	FACS	Human	NA	Case	F50	NA	50219	P3	F09	NA	Customer Extracted	Q5	12.63	NA	12.63	2.4	2.4	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	AACTGCGATATG	CTGGAAATCTGC	IgM+IgA-	4A	run6	Y	NA	NA	000000000-CD29D
I.50.1.MpAp.4	CTGGAAATCTGCCTTCCAACTCAT	GGACTACNVGGGTWTCTAAT	161	F50.1	FACS	Human	NA	Case	F50	NA	50219	P3	G09	NA	Customer Extracted	Q5	13.74	NA	13.74	2.2	2.2	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	CTTCCAACTCAT	CTGGAAATCTGC	IgM+IgA+	4A	run6	Y	NA	NA	000000000-CD29D
I.50.1.Neg.4	CTGGAAATCTGCTCGCCGTGTACA	GGACTACNVGGGTWTCTAAT	159	F50.1	FACS	Human	NA	Case	F50	NA	50219	P3	E09	NA	Customer Extracted	Q5	0.63	NA	0.63	47.6	35	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	TCGCCGTGTACA	CTGGAAATCTGC	IgA-IgM-IgG-	4A	run6	Y	NA	NA	000000000-CD29D
I.50.1.Neg.5	CTGGAAATCTGCTGTACATCGCCG	GGACTACNVGGGTWTCTAAT	163	F50.1	FACS	Human	NA	Case	F50	NA	50219	P3	A10	NA	Customer Extracted	Q5	0.29	NA	0.29	103.4	35	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	TGTACATCGCCG	CTGGAAATCTGC	IgA-IgM-IgG-	5A	run6	Y	NA	NA	000000000-CD29D
I.50.2.GnAp.5	CTGGAAATCTGCAGGAACCAGACG	GGACTACNVGGGTWTCTAAT	178	F50.2	FACS	Human	NA	Control	F50	NA	50219	P3	H11	NA	Customer Extracted	Q5	0.83	NA	0.83	36.1	35	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	AGGAACCAGACG	CTGGAAATCTGC	IgA+IgG-	5A	run6	Y	NA	NA	000000000-CD29D
I.50.2.GnMp.5	CTGGAAATCTGCAAGGGCGCTGAA	GGACTACNVGGGTWTCTAAT	176	F50.2	FACS	Human	NA	Control	F50	NA	50219	P3	F11	NA	Customer Extracted	Q5	14.02	NA	14.02	2.1	2.1	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	AAGGGCGCTGAA	CTGGAAATCTGC	IgM+IgG-	5A	run6	Y	NA	NA	000000000-CD29D
I.50.2.GpAp.5	CTGGAAATCTGCGTTTCCGTGGTG	GGACTACNVGGGTWTCTAAT	177	F50.2	FACS	Human	NA	Control	F50	NA	50219	P3	G11	NA	Customer Extracted	Q5	9.88	NA	9.88	3	3	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	GTTTCCGTGGTG	CTGGAAATCTGC	IgG+IgA+	5A	run6	Y	NA	NA	000000000-CD29D
I.50.2.GpMn.5	CTGGAAATCTGCATAGGCTGTAGT	GGACTACNVGGGTWTCTAAT	174	F50.2	FACS	Human	NA	Control	F50	NA	50219	P3	D11	NA	Customer Extracted	Q5	4.62	NA	4.62	6.5	6.5	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	ATAGGCTGTAGT	CTGGAAATCTGC	IgG+IgM-	5A	run6	Y	NA	NA	000000000-CD29D
I.50.2.GpMp.5	CTGGAAATCTGCTGTGTAGCCATG	GGACTACNVGGGTWTCTAAT	175	F50.2	FACS	Human	NA	Control	F50	NA	50219	P3	E11	NA	Customer Extracted	Q5	12.65	NA	12.65	2.4	2.4	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	TGTGTAGCCATG	CTGGAAATCTGC	IgG+IgM+	5A	run6	Y	NA	NA	000000000-CD29D
I.50.2.MnAp.4	CTGGAAATCTGCCTGTGTCCATGG	GGACTACNVGGGTWTCTAAT	172	F50.2	FACS	Human	NA	Control	F50	NA	50219	P3	B11	NA	Customer Extracted	Q5	12.58	NA	12.58	2.4	2.4	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	CTGTGTCCATGG	CTGGAAATCTGC	IgA+IgM-	4A	run6	Y	NA	NA	000000000-CD29D
I.50.2.MpAn.4	CTGGAAATCTGCAATAGCATGTCG	GGACTACNVGGGTWTCTAAT	170	F50.2	FACS	Human	NA	Control	F50	NA	50219	P3	H10	NA	Customer Extracted	Q5	10.16	NA	10.16	3	3	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	AATAGCATGTCG	CTGGAAATCTGC	IgM+IgA-	4A	run6	Y	NA	NA	000000000-CD29D
I.50.2.MpAp.4	CTGGAAATCTGCCGGAGTAATCCT	GGACTACNVGGGTWTCTAAT	171	F50.2	FACS	Human	NA	Control	F50	NA	50219	P3	A11	NA	Customer Extracted	Q5	17.23	NA	17.23	1.7	1.7	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	CGGAGTAATCCT	CTGGAAATCTGC	IgM+IgA+	4A	run6	Y	NA	NA	000000000-CD29D
I.50.2.Neg.4	CTGGAAATCTGCGAGGACCAGCAA	GGACTACNVGGGTWTCTAAT	169	F50.2	FACS	Human	NA	Control	F50	NA	50219	P3	G10	NA	Customer Extracted	Q5	1.01	NA	1.01	29.7	29.7	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	GAGGACCAGCAA	CTGGAAATCTGC	IgA-IgM-IgG-	4A	run6	Y	NA	NA	000000000-CD29D
I.50.2.Neg.5	CTGGAAATCTGCCTTCGCGGATGT	GGACTACNVGGGTWTCTAAT	173	F50.2	FACS	Human	NA	Control	F50	NA	50219	P3	C11	NA	Customer Extracted	Q5	0.65	NA	0.65	46.2	35	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	CTTCGCGGATGT	CTGGAAATCTGC	IgA-IgM-IgG-	5A	run6	Y	NA	NA	000000000-CD29D
I.51.1.GnMp.5	CTGGAAATCTGCCTAGCTATGGAC	GGACTACNVGGGTWTCTAAT	184	F51.1	FACS	Human	NA	Case	F51	NA	50119	P3	G12	NA	Customer Extracted	Q5	11.55	NA	11.55	2.6	2.6	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	CTAGCTATGGAC	CTGGAAATCTGC	IgM+IgG-	5A	run7	Y	NA	NA	000000000-CD29D
I.51.1.GpMn.5	CTGGAAATCTGCTCAGTCAGATGA	GGACTACNVGGGTWTCTAAT	182	F51.1	FACS	Human	NA	Case	F51	NA	50119	P3	D12	NA	Customer Extracted	Q5	11.48	NA	11.48	2.6	2.6	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	TCAGTCAGATGA	CTGGAAATCTGC	IgG+IgM-	5A	run7	Y	NA	NA	000000000-CD29D
I.51.1.GpMp.5	CTGGAAATCTGCGCTGTGATTCGA	GGACTACNVGGGTWTCTAAT	183	F51.1	FACS	Human	NA	Case	F51	NA	50119	P3	F12	NA	Customer Extracted	Q5	13.38	NA	13.38	2.2	2.2	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	GCTGTGATTCGA	CTGGAAATCTGC	IgG+IgM+	5A	run7	Y	NA	NA	000000000-CD29D
I.51.1.MpAn.4	CTGGAAATCTGCTATGAACGTCCG	GGACTACNVGGGTWTCTAAT	180	F51.1	FACS	Human	NA	Case	F51	NA	50119	P3	B12	NA	Customer Extracted	Q5	12.26	NA	12.26	2.4	2.4	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	TATGAACGTCCG	CTGGAAATCTGC	IgM+IgA-	4A	run7	Y	NA	NA	000000000-CD29D
I.51.1.Neg.4	CTGGAAATCTGCTAATGCCCAGGT	GGACTACNVGGGTWTCTAAT	179	F51.1	FACS	Human	NA	Case	F51	NA	50119	P3	A12	NA	Customer Extracted	Q5	3.75	NA	3.75	8	8	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	TAATGCCCAGGT	CTGGAAATCTGC	IgA-IgM-IgG-	4A	run7	Y	NA	NA	000000000-CD29D
I.51.1.Neg.5	CTGGAAATCTGCCCACATTGGGTC	GGACTACNVGGGTWTCTAAT	181	F51.1	FACS	Human	NA	Case	F51	NA	50119	P3	C12	NA	Customer Extracted	Q5	12.74	NA	12.74	2.4	2.4	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	CCACATTGGGTC	CTGGAAATCTGC	IgA-IgM-IgG-	5A	run7	Y	NA	NA	000000000-CD29D
I.51.2.GnAp.5	TGAGGATGATAGGGTCTCCTACAG	GGACTACNVGGGTWTCTAAT	194	F51.2	FACS	Human	NA	Control	F51	NA	50119	P4	A02	0.01	Customer Extracted	Q5	8.74	NA	8.74	3.4	3.4	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	GGTCTCCTACAG	TGAGGATGATAG	IgA+IgG-	5A	run7	Y	NA	0.01	000000000-CD29D
I.51.2.GnMp.5	TGAGGATGATAGGAGAGTCCACTT	GGACTACNVGGGTWTCTAAT	191	F51.2	FACS	Human	NA	Control	F51	NA	50119	P4	F01	0.02	Customer Extracted	Q5	5.64	NA	5.64	5.3	5.3	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	GAGAGTCCACTT	TGAGGATGATAG	IgM+IgG-	5A	run7	Y	NA	0.02	000000000-CD29D
I.51.2.GpAn.5	TGAGGATGATAGGAACGGGACGTA	GGACTACNVGGGTWTCTAAT	192	F51.2	FACS	Human	NA	Control	F51	NA	50119	P4	G01	0.05	Customer Extracted	Q5	4.29	NA	4.29	7	7	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	GAACGGGACGTA	TGAGGATGATAG	IgG+IgA-	5A	run7	Y	NA	0.05	000000000-CD29D
I.51.2.GpAp.5	TGAGGATGATAGACGTGTAGGCTT	GGACTACNVGGGTWTCTAAT	193	F51.2	FACS	Human	NA	Control	F51	NA	50119	P4	H01	0.02	Customer Extracted	Q5	8.08	NA	8.08	3.7	3.7	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	ACGTGTAGGCTT	TGAGGATGATAG	IgG+IgA+	5A	run7	Y	NA	0.02	000000000-CD29D
I.51.2.GpMp.5	TGAGGATGATAGCCAGATATAGCA	GGACTACNVGGGTWTCTAAT	190	F51.2	FACS	Human	NA	Control	F51	NA	50119	P4	E01	0.01	Customer Extracted	Q5	8.46	NA	8.46	3.5	3.5	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	CCAGATATAGCA	TGAGGATGATAG	IgG+IgM+	5A	run7	Y	NA	0.01	000000000-CD29D
I.51.2.MnAp.4	TGAGGATGATAGAATGACCTCGTG	GGACTACNVGGGTWTCTAAT	188	F51.2	FACS	Human	NA	Control	F51	NA	50119	P4	C01	0.01	Customer Extracted	Q5	4.02	NA	4.02	7.5	7.5	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	AATGACCTCGTG	TGAGGATGATAG	IgA+IgM-	4A	run7	Y	NA	0.01	000000000-CD29D
I.51.2.MpAn.4	TGAGGATGATAGACTCTAGCCGGT	GGACTACNVGGGTWTCTAAT	186	F51.2	FACS	Human	NA	Control	F51	NA	50119	P4	A01	0.01	Customer Extracted	Q5	0.41	NA	0.41	73.2	35	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	ACTCTAGCCGGT	TGAGGATGATAG	IgM+IgA-	4A	run7	Y	NA	0.01	000000000-CD29D
I.51.2.MpAp.4	TGAGGATGATAGCGATAGGCCTTA	GGACTACNVGGGTWTCTAAT	187	F51.2	FACS	Human	NA	Control	F51	NA	50119	P4	B01	0.01	Customer Extracted	Q5	7.81	NA	7.81	3.8	3.8	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	CGATAGGCCTTA	TGAGGATGATAG	IgM+IgA+	4A	run7	Y	NA	0.01	000000000-CD29D
I.51.2.Neg.4	CTGGAAATCTGCCTTGACGAGGTT	GGACTACNVGGGTWTCTAAT	185	F51.2	FACS	Human	NA	Control	F51	NA	50119	P3	H12	NA	Customer Extracted	Q5	11.41	NA	11.41	2.6	2.6	TRUE	000000000-CD29D	20190701	Silvermen	19133	19137	CTTGACGAGGTT	CTGGAAATCTGC	IgA-IgM-IgG-	4A	run7	Y	NA	NA	000000000-CD29D
I.51.2.Neg.5	TGAGGATGATAGCTTAGGCATGTG	GGACTACNVGGGTWTCTAAT	189	F51.2	FACS	Human	NA	Control	F51	NA	50119	P4	D01	0.01	Customer Extracted	Q5	6.42	NA	6.42	4.7	4.7	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	CTTAGGCATGTG	TGAGGATGATAG	IgA-IgM-IgG-	5A	run7	Y	NA	0.01	000000000-CD29D
I.52.1.GnMp.5	TGAGGATGATAGTGGCTTTCTATC	GGACTACNVGGGTWTCTAAT	199	F52.1	FACS	Human	NA	Case	F52	NA	41819	P4	F02	0.03	Customer Extracted	Q5	7.61	NA	7.61	3.9	3.9	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	TGGCTTTCTATC	TGAGGATGATAG	IgM+IgG-	5A	run6	Y	NA	0.03	000000000-CD29D
I.52.1.GpMp.5	TGAGGATGATAGATTAAGCCTGGA	GGACTACNVGGGTWTCTAAT	198	F52.1	FACS	Human	NA	Case	F52	NA	41819	P4	E02	0.03	Customer Extracted	Q5	5	NA	5	6	6	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	ATTAAGCCTGGA	TGAGGATGATAG	IgG+IgM+	5A	run6	Y	NA	0.03	000000000-CD29D
I.52.1.MpAn.4	TGAGGATGATAGGATGCTGCCGTT	GGACTACNVGGGTWTCTAAT	196	F52.1	FACS	Human	NA	Case	F52	NA	41819	P4	C02	0.02	Customer Extracted	Q5	7.19	NA	7.19	4.2	4.2	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	GATGCTGCCGTT	TGAGGATGATAG	IgM+IgA-	4A	run6	Y	NA	0.02	000000000-CD29D
I.52.1.Neg.4	TGAGGATGATAGACTGACTTAAGG	GGACTACNVGGGTWTCTAAT	195	F52.1	FACS	Human	NA	Case	F52	NA	41819	P4	B02	0.01	Customer Extracted	Q5	1.03	NA	1.03	29.1	29.1	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	ACTGACTTAAGG	TGAGGATGATAG	IgA-IgM-IgG-	4A	run6	Y	NA	0.01	000000000-CD29D
I.52.1.Neg.5	TGAGGATGATAGTTCCTAGGCCAG	GGACTACNVGGGTWTCTAAT	197	F52.1	FACS	Human	NA	Case	F52	NA	41819	P4	D02	0.01	Customer Extracted	Q5	2.96	NA	2.96	10.1	10.1	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	TTCCTAGGCCAG	TGAGGATGATAG	IgA-IgM-IgG-	5A	run6	Y	NA	0.01	000000000-CD29D
I.52.2.GnAp.5	TGAGGATGATAGGCGTTGCAAACT	GGACTACNVGGGTWTCTAAT	210	F52.2	FACS	Human	NA	Control	F52	NA	41819	P4	C04	0.01	Customer Extracted	Q5	9.28	NA	9.28	3.2	3.2	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	GCGTTGCAAACT	TGAGGATGATAG	IgA+IgG-	5A	run6	Y	NA	0.01	000000000-CD29D
I.52.2.GnMp.5	TGAGGATGATAGTAACGCTGTGTG	GGACTACNVGGGTWTCTAAT	207	F52.2	FACS	Human	NA	Control	F52	NA	41819	P4	F03	0.01	Customer Extracted	Q5	9.79	NA	9.79	3.1	3.1	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	TAACGCTGTGTG	TGAGGATGATAG	IgM+IgG-	5A	run6	Y	NA	0.01	000000000-CD29D
I.52.2.GpAn.5	TGAGGATGATAGGCCGTCTCGTAA	GGACTACNVGGGTWTCTAAT	208	F52.2	FACS	Human	NA	Control	F52	NA	41819	P4	H03	0.04	Customer Extracted	Q5	2.7	NA	2.7	11.1	11.1	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	GCCGTCTCGTAA	TGAGGATGATAG	IgG+IgA-	5A	run6	Y	NA	0.04	000000000-CD29D
I.52.2.GpAp.5	TGAGGATGATAGGACTACCCGTTG	GGACTACNVGGGTWTCTAAT	209	F52.2	FACS	Human	NA	Control	F52	NA	41819	P4	B04	0.02	Customer Extracted	Q5	5.31	NA	5.31	5.6	5.6	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	GACTACCCGTTG	TGAGGATGATAG	IgG+IgA+	5A	run6	Y	NA	0.02	000000000-CD29D
I.52.2.GpMn.5	TGAGGATGATAGTACGGATTATGG	GGACTACNVGGGTWTCTAAT	205	F52.2	FACS	Human	NA	Control	F52	NA	41819	P4	D03	0.01	Customer Extracted	Q5	8.94	NA	8.94	3.4	3.4	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	TACGGATTATGG	TGAGGATGATAG	IgG+IgM-	5A	run6	Y	NA	0.01	000000000-CD29D
I.52.2.GpMp.5	TGAGGATGATAGATAGCGAACTCA	GGACTACNVGGGTWTCTAAT	206	F52.2	FACS	Human	NA	Control	F52	NA	41819	P4	E03	0.02	Customer Extracted	Q5	11	NA	11	2.7	2.7	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	ATAGCGAACTCA	TGAGGATGATAG	IgG+IgM+	5A	run6	Y	NA	0.02	000000000-CD29D
I.52.2.MnAp.4	TGAGGATGATAGGATCTCTGGGTA	GGACTACNVGGGTWTCTAAT	203	F52.2	FACS	Human	NA	Control	F52	NA	41819	P4	B03	0.01	Customer Extracted	Q5	11.15	NA	11.15	2.7	2.7	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	GATCTCTGGGTA	TGAGGATGATAG	IgA+IgM-	4A	run6	Y	NA	0.01	000000000-CD29D
I.52.2.MpAn.4	TGAGGATGATAGGAGCGTATCCAT	GGACTACNVGGGTWTCTAAT	201	F52.2	FACS	Human	NA	Control	F52	NA	41819	P4	H02	0.02	Customer Extracted	Q5	7.92	NA	7.92	3.8	3.8	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	GAGCGTATCCAT	TGAGGATGATAG	IgM+IgA-	4A	run6	Y	NA	0.02	000000000-CD29D
I.52.2.MpAp.4	TGAGGATGATAGATGGGCGAATGG	GGACTACNVGGGTWTCTAAT	202	F52.2	FACS	Human	NA	Control	F52	NA	41819	P4	A03	0.05	Customer Extracted	Q5	13.25	NA	13.25	2.3	2.3	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	ATGGGCGAATGG	TGAGGATGATAG	IgM+IgA+	4A	run6	Y	NA	0.05	000000000-CD29D
I.52.2.Neg.4	TGAGGATGATAGACAGCTCAAACA	GGACTACNVGGGTWTCTAAT	200	F52.2	FACS	Human	NA	Control	F52	NA	41819	P4	G02	0.02	Customer Extracted	Q5	8.65	NA	8.65	3.5	3.5	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	ACAGCTCAAACA	TGAGGATGATAG	IgA-IgM-IgG-	4A	run6	Y	NA	0.02	000000000-CD29D
I.52.2.Neg.5	TGAGGATGATAGCATCATACGGGT	GGACTACNVGGGTWTCTAAT	204	F52.2	FACS	Human	NA	Control	F52	NA	41819	P4	C03	0.01	Customer Extracted	Q5	5.69	NA	5.69	5.3	5.3	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	CATCATACGGGT	TGAGGATGATAG	IgA-IgM-IgG-	5A	run6	Y	NA	0.01	000000000-CD29D
I.52.3.GnMp.5	TGAGGATGATAGGAAATGCTACGT	GGACTACNVGGGTWTCTAAT	218	F52.3	FACS	Human	NA	Control	F52	NA	41819	P4	C05	0.02	Customer Extracted	Q5	10.16	NA	10.16	3	3	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	GAAATGCTACGT	TGAGGATGATAG	IgM+IgG-	5A	run6	Y	NA	0.02	000000000-CD29D
I.52.3.GpMn.5	TGAGGATGATAGCTTGAGAAATCG	GGACTACNVGGGTWTCTAAT	216	F52.3	FACS	Human	NA	Control	F52	NA	41819	P4	A05	0.03	Customer Extracted	Q5	7.11	NA	7.11	4.2	4.2	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	CTTGAGAAATCG	TGAGGATGATAG	IgG+IgM-	5A	run6	Y	NA	0.03	000000000-CD29D
I.52.3.GpMp.5	TGAGGATGATAGCTACACAGCACA	GGACTACNVGGGTWTCTAAT	217	F52.3	FACS	Human	NA	Control	F52	NA	41819	P4	B05	0.03	Customer Extracted	Q5	6.83	NA	6.83	4.4	4.4	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	CTACACAGCACA	TGAGGATGATAG	IgG+IgM+	5A	run6	Y	NA	0.03	000000000-CD29D
I.52.3.MnAp.4	TGAGGATGATAGCGCATTTGGATG	GGACTACNVGGGTWTCTAAT	214	F52.3	FACS	Human	NA	Control	F52	NA	41819	P4	G04	0.03	Customer Extracted	Q5	9.54	NA	9.54	3.1	3.1	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	CGCATTTGGATG	TGAGGATGATAG	IgA+IgM-	4A	run6	Y	NA	0.03	000000000-CD29D
I.52.3.MpAn.4	TGAGGATGATAGACCTTACACCTT	GGACTACNVGGGTWTCTAAT	212	F52.3	FACS	Human	NA	Control	F52	NA	41819	P4	E04	0.01	Customer Extracted	Q5	8.14	NA	8.14	3.7	3.7	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	ACCTTACACCTT	TGAGGATGATAG	IgM+IgA-	4A	run6	Y	NA	0.01	000000000-CD29D
I.52.3.MpAp.4	TGAGGATGATAGGTAGGTGCTTAC	GGACTACNVGGGTWTCTAAT	213	F52.3	FACS	Human	NA	Control	F52	NA	41819	P4	F04	0	Customer Extracted	Q5	5.85	NA	5.85	5.1	5.1	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	GTAGGTGCTTAC	TGAGGATGATAG	IgM+IgA+	4A	run6	Y	NA	0	000000000-CD29D
I.52.3.Neg.4	TGAGGATGATAGAACCGCATAAGT	GGACTACNVGGGTWTCTAAT	211	F52.3	FACS	Human	NA	Control	F52	NA	41819	P4	D04	0.01	Customer Extracted	Q5	0.99	NA	0.99	30.3	30.3	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	AACCGCATAAGT	TGAGGATGATAG	IgA-IgM-IgG-	4A	run6	Y	NA	0.01	000000000-CD29D
I.52.3.Neg.5	TGAGGATGATAGATAACATGTGCG	GGACTACNVGGGTWTCTAAT	215	F52.3	FACS	Human	NA	Control	F52	NA	41819	P4	H04	0.01	Customer Extracted	Q5	14.89	NA	14.89	2	2	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	ATAACATGTGCG	TGAGGATGATAG	IgA-IgM-IgG-	5A	run6	Y	NA	0.01	000000000-CD29D
I.54.1.GnMp.5	TGAGGATGATAGCCAGACCGCTAT	GGACTACNVGGGTWTCTAAT	224	F54.1	FACS	Human	NA	Case	F54	NA	50919	P4	A06	0.01	Customer Extracted	Q5	8.91	NA	8.91	3.4	3.4	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	CCAGACCGCTAT	TGAGGATGATAG	IgM+IgG-	5A	run5	Y	NA	0.01	000000000-CD29D
I.54.1.GpMn.5	TGAGGATGATAGGATCCTCATGCG	GGACTACNVGGGTWTCTAAT	222	F54.1	FACS	Human	NA	Case	F54	NA	50919	P4	G05	0.01	Customer Extracted	Q5	12.08	NA	12.08	2.5	2.5	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	GATCCTCATGCG	TGAGGATGATAG	IgG+IgM-	5A	run5	Y	NA	0.01	000000000-CD29D
I.54.1.GpMp.5	TGAGGATGATAGATTATCGTCCCT	GGACTACNVGGGTWTCTAAT	223	F54.1	FACS	Human	NA	Case	F54	NA	50919	P4	H05	0.05	Customer Extracted	Q5	12.63	NA	12.63	2.4	2.4	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	ATTATCGTCCCT	TGAGGATGATAG	IgG+IgM+	5A	run5	Y	NA	0.05	000000000-CD29D
I.54.1.MpAn.4	TGAGGATGATAGGATCATTCTCTC	GGACTACNVGGGTWTCTAAT	220	F54.1	FACS	Human	NA	Case	F54	NA	50919	P4	E05	0.01	Customer Extracted	Q5	9.82	NA	9.82	3.1	3.1	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	GATCATTCTCTC	TGAGGATGATAG	IgM+IgA-	4A	run5	Y	NA	0.01	000000000-CD29D
I.54.1.Neg.4	TGAGGATGATAGTCTGAGGTTGCC	GGACTACNVGGGTWTCTAAT	219	F54.1	FACS	Human	NA	Case	F54	NA	50919	P4	D05	0.01	Customer Extracted	Q5	8.22	NA	8.22	3.6	3.6	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	TCTGAGGTTGCC	TGAGGATGATAG	IgA-IgM-IgG-	4A	run5	Y	NA	0.01	000000000-CD29D
I.54.1.Neg.5	TGAGGATGATAGAGACATACCGTA	GGACTACNVGGGTWTCTAAT	221	F54.1	FACS	Human	NA	Case	F54	NA	50919	P4	F05	0.05	Customer Extracted	Q5	8.15	NA	8.15	3.7	3.7	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	AGACATACCGTA	TGAGGATGATAG	IgA-IgM-IgG-	5A	run5	Y	NA	0.05	000000000-CD29D
I.54.2.GnAp.5	TGAGGATGATAGTAAAGACCCGTA	GGACTACNVGGGTWTCTAAT	232	F54.2	FACS	Human	NA	Control	F54	NA	50919	P4	A07	0.01	Customer Extracted	Q5	3.85	NA	3.85	7.8	7.8	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	TAAAGACCCGTA	TGAGGATGATAG	IgA+IgG-	5A	run5	Y	NA	0.01	000000000-CD29D
I.54.2.GnMp.5	TGAGGATGATAGTCCAACTGCAGA	GGACTACNVGGGTWTCTAAT	231	F54.2	FACS	Human	NA	Control	F54	NA	50919	P4	H06	0.01	Customer Extracted	Q5	12.56	NA	12.56	2.4	2.4	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	TCCAACTGCAGA	TGAGGATGATAG	IgM+IgG-	5A	run5	Y	NA	0.01	000000000-CD29D
I.54.2.GpMp.5	TGAGGATGATAGCGCCATTGTGCA	GGACTACNVGGGTWTCTAAT	230	F54.2	FACS	Human	NA	Control	F54	NA	50919	P4	G06	0.02	Customer Extracted	Q5	14.3	NA	14.3	2.1	2.1	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	CGCCATTGTGCA	TGAGGATGATAG	IgG+IgM+	5A	run5	Y	NA	0.02	000000000-CD29D
I.54.2.MnAp.4	TGAGGATGATAGGCGAAGTTGGGA	GGACTACNVGGGTWTCTAAT	228	F54.2	FACS	Human	NA	Control	F54	NA	50919	P4	E06	0	Customer Extracted	Q5	9.8	NA	9.8	3.1	3.1	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	GCGAAGTTGGGA	TGAGGATGATAG	IgA+IgM-	4A	run5	Y	NA	0	000000000-CD29D
I.54.2.MpAn.4	TGAGGATGATAGTCCATCGACGTG	GGACTACNVGGGTWTCTAAT	226	F54.2	FACS	Human	NA	Control	F54	NA	50919	P4	C06	0.02	Customer Extracted	Q5	8.82	NA	8.82	3.4	3.4	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	TCCATCGACGTG	TGAGGATGATAG	IgM+IgA-	4A	run5	Y	NA	0.02	000000000-CD29D
I.54.2.MpAp.4	TGAGGATGATAGCGATGTGTGGTT	GGACTACNVGGGTWTCTAAT	227	F54.2	FACS	Human	NA	Control	F54	NA	50919	P4	D06	0.02	Customer Extracted	Q5	10.84	NA	10.84	2.8	2.8	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	CGATGTGTGGTT	TGAGGATGATAG	IgM+IgA+	4A	run5	Y	NA	0.02	000000000-CD29D
I.54.2.Neg.4	TGAGGATGATAGAGCTCTAGAAAC	GGACTACNVGGGTWTCTAAT	225	F54.2	FACS	Human	NA	Control	F54	NA	50919	P4	B06	0	Customer Extracted	Q5	0.78	NA	0.78	38.5	35	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	AGCTCTAGAAAC	TGAGGATGATAG	IgA-IgM-IgG-	4A	run5	Y	NA	0	000000000-CD29D
I.54.2.Neg.5	TGAGGATGATAGGCATTCGGCGTT	GGACTACNVGGGTWTCTAAT	229	F54.2	FACS	Human	NA	Control	F54	NA	50919	P4	F06	0	Customer Extracted	Q5	4.43	NA	4.43	6.8	6.8	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	GCATTCGGCGTT	TGAGGATGATAG	IgA-IgM-IgG-	5A	run5	Y	NA	0	000000000-CD29D
I.59.1.GnMp.5	TGAGGATGATAGGGCGATTTACGT	GGACTACNVGGGTWTCTAAT	237	F59.1	FACS	Human	NA	Case	F59	NA	52219	P4	F07	0	Customer Extracted	Q5	8.41	NA	8.41	3.6	3.6	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	GGCGATTTACGT	TGAGGATGATAG	IgM+IgG-	5A	run5	Y	NA	0	000000000-CD29D
I.59.1.GpMp.5	TGAGGATGATAGGACGCACTAACT	GGACTACNVGGGTWTCTAAT	236	F59.1	FACS	Human	NA	Case	F59	NA	52219	P4	E07	0.01	Customer Extracted	Q5	9.2	NA	9.2	3.3	3.3	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	GACGCACTAACT	TGAGGATGATAG	IgG+IgM+	5A	run5	Y	NA	0.01	000000000-CD29D
I.59.1.MpAn.4	TGAGGATGATAGGACTGACTCGTC	GGACTACNVGGGTWTCTAAT	234	F59.1	FACS	Human	NA	Case	F59	NA	52219	P4	C07	0.01	Customer Extracted	Q5	3.61	NA	3.61	8.3	8.3	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	GACTGACTCGTC	TGAGGATGATAG	IgM+IgA-	4A	run5	Y	NA	0.01	000000000-CD29D
I.59.1.Neg.4	TGAGGATGATAGTGTATCTTCACC	GGACTACNVGGGTWTCTAAT	233	F59.1	FACS	Human	NA	Case	F59	NA	52219	P4	B07	0.01	Customer Extracted	Q5	0.83	NA	0.83	36.1	35	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	TGTATCTTCACC	TGAGGATGATAG	IgA-IgM-IgG-	4A	run5	Y	NA	0.01	000000000-CD29D
I.59.1.Neg.5	TGAGGATGATAGTCGTGGATAGCT	GGACTACNVGGGTWTCTAAT	235	F59.1	FACS	Human	NA	Case	F59	NA	52219	P4	D07	0	Customer Extracted	Q5	0.85	NA	0.85	35.3	35	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	TCGTGGATAGCT	TGAGGATGATAG	IgA-IgM-IgG-	5A	run5	Y	NA	0	000000000-CD29D
I.59.2.GnMp.5	TGAGGATGATAGCTACGAAAGCCT	GGACTACNVGGGTWTCTAAT	242	F59.2	FACS	Human	NA	Control	F59	NA	52219	P4	C08	0.01	Customer Extracted	Q5	2.57	NA	2.57	11.7	11.7	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	CTACGAAAGCCT	TGAGGATGATAG	IgM+IgG-	5A	run5	Y	NA	0.01	000000000-CD29D
I.59.2.GpMp.5	TGAGGATGATAGCAGTCGTTAAGA	GGACTACNVGGGTWTCTAAT	241	F59.2	FACS	Human	NA	Control	F59	NA	52219	P4	B08	0.01	Customer Extracted	Q5	13.52	NA	13.52	2.2	2.2	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	CAGTCGTTAAGA	TGAGGATGATAG	IgG+IgM+	5A	run5	Y	NA	0.01	000000000-CD29D
I.59.2.MpAn.4	TGAGGATGATAGACCCATACAGCC	GGACTACNVGGGTWTCTAAT	239	F59.2	FACS	Human	NA	Control	F59	NA	52219	P4	H07	0.01	Customer Extracted	Q5	2.22	NA	2.22	13.5	13.5	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	ACCCATACAGCC	TGAGGATGATAG	IgM+IgA-	4A	run5	Y	NA	0.01	000000000-CD29D
I.59.2.Neg.4	TGAGGATGATAGTAAGGCATCGCT	GGACTACNVGGGTWTCTAAT	238	F59.2	FACS	Human	NA	Control	F59	NA	52219	P4	G07	0	Customer Extracted	Q5	3.77	NA	3.77	8	8	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	TAAGGCATCGCT	TGAGGATGATAG	IgA-IgM-IgG-	4A	run5	Y	NA	0	000000000-CD29D
I.59.2.Neg.5	TGAGGATGATAGCGCACTACGCAT	GGACTACNVGGGTWTCTAAT	240	F59.2	FACS	Human	NA	Control	F59	NA	52219	P4	A08	0	Customer Extracted	Q5	1.58	NA	1.58	19	19	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	CGCACTACGCAT	TGAGGATGATAG	IgA-IgM-IgG-	5A	run5	Y	NA	0	000000000-CD29D
I.63.1.GnMp.5	TGAGGATGATAGCTCTTCTGATCA	GGACTACNVGGGTWTCTAAT	247	F63.1	FACS	Human	NA	Case	F63	NA	52319	P4	H08	0.01	Customer Extracted	Q5	11.55	NA	11.55	2.6	2.6	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	CTCTTCTGATCA	TGAGGATGATAG	IgM+IgG-	5A	run7	Y	NA	0.01	000000000-CD29D
I.63.1.GpMp.5	TGAGGATGATAGCTACTTACATCC	GGACTACNVGGGTWTCTAAT	246	F63.1	FACS	Human	NA	Case	F63	NA	52319	P4	G08	0.01	Customer Extracted	Q5	12.09	NA	12.09	2.5	2.5	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	CTACTTACATCC	TGAGGATGATAG	IgG+IgM+	5A	run7	Y	NA	0.01	000000000-CD29D
I.63.1.MpAn.4	TGAGGATGATAGGGCATGTTATCG	GGACTACNVGGGTWTCTAAT	244	F63.1	FACS	Human	NA	Case	F63	NA	52319	P4	E08	0.01	Customer Extracted	Q5	11.01	NA	11.01	2.7	2.7	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	GGCATGTTATCG	TGAGGATGATAG	IgM+IgA-	4A	run7	Y	NA	0.01	000000000-CD29D
I.63.1.Neg.4	TGAGGATGATAGATAATTGCCGAG	GGACTACNVGGGTWTCTAAT	243	F63.1	FACS	Human	NA	Case	F63	NA	52319	P4	D08	0.02	Customer Extracted	Q5	6.19	NA	6.19	4.8	4.8	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	ATAATTGCCGAG	TGAGGATGATAG	IgA-IgM-IgG-	4A	run7	Y	NA	0.02	000000000-CD29D
I.63.1.Neg.5	TGAGGATGATAGAGGCACAGTAGG	GGACTACNVGGGTWTCTAAT	245	F63.1	FACS	Human	NA	Case	F63	NA	52319	P4	F08	0.02	Customer Extracted	Q5	7.41	NA	7.41	4	4	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	AGGCACAGTAGG	TGAGGATGATAG	IgA-IgM-IgG-	5A	run7	Y	NA	0.02	000000000-CD29D
I.63.2.GnAp.5	TGAGGATGATAGTGTTAAGCAGCA	GGACTACNVGGGTWTCTAAT	256	F63.2	FACS	Human	NA	Control	F63	NA	52319	P4	B10	0.01	Customer Extracted	Q5	6.31	NA	6.31	4.8	4.8	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	TGTTAAGCAGCA	TGAGGATGATAG	IgA+IgG-	5A	run7	Y	NA	0.01	000000000-CD29D
I.63.2.GnMp.5	TGAGGATGATAGGAGATCGCCTAT	GGACTACNVGGGTWTCTAAT	254	F63.2	FACS	Human	NA	Control	F63	NA	52319	P4	H09	0.01	Customer Extracted	Q5	6.86	NA	6.86	4.4	4.4	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	GAGATCGCCTAT	TGAGGATGATAG	IgM+IgG-	5A	run7	Y	NA	0.01	000000000-CD29D
I.63.2.GpAp.5	TGAGGATGATAGTGTACATCGCCG	GGACTACNVGGGTWTCTAAT	255	F63.2	FACS	Human	NA	Control	F63	NA	52319	P4	A10	0.01	Customer Extracted	Q5	7.49	NA	7.49	4	4	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	TGTACATCGCCG	TGAGGATGATAG	IgG+IgA+	5A	run7	Y	NA	0.01	000000000-CD29D
I.63.2.GpMp.5	TGAGGATGATAGCTTCCAACTCAT	GGACTACNVGGGTWTCTAAT	253	F63.2	FACS	Human	NA	Control	F63	NA	52319	P4	G09	0.02	Customer Extracted	Q5	7.94	NA	7.94	3.8	3.8	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	CTTCCAACTCAT	TGAGGATGATAG	IgG+IgM+	5A	run7	Y	NA	0.02	000000000-CD29D
I.63.2.MnAp.4	TGAGGATGATAGTCGCCGTGTACA	GGACTACNVGGGTWTCTAAT	251	F63.2	FACS	Human	NA	Control	F63	NA	52319	P4	E09	0.01	Customer Extracted	Q5	7.12	NA	7.12	4.2	4.2	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	TCGCCGTGTACA	TGAGGATGATAG	IgA+IgM-	4A	run7	Y	NA	0.01	000000000-CD29D
I.63.2.MpAn.4	TGAGGATGATAGACCAATCTCGGC	GGACTACNVGGGTWTCTAAT	249	F63.2	FACS	Human	NA	Control	F63	NA	52319	P4	B09	0.03	Customer Extracted	Q5	6.16	NA	6.16	4.9	4.9	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	ACCAATCTCGGC	TGAGGATGATAG	IgM+IgA-	4A	run7	Y	NA	0.03	000000000-CD29D
I.63.2.MpAp.4	TGAGGATGATAGGTACTGAAGATC	GGACTACNVGGGTWTCTAAT	250	F63.2	FACS	Human	NA	Control	F63	NA	52319	P4	D09	0.01	Customer Extracted	Q5	14.48	NA	14.48	2.1	2.1	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	GTACTGAAGATC	TGAGGATGATAG	IgM+IgA+	4A	run7	Y	NA	0.01	000000000-CD29D
I.63.2.Neg.4	TGAGGATGATAGATGCTAACCACG	GGACTACNVGGGTWTCTAAT	248	F63.2	FACS	Human	NA	Control	F63	NA	52319	P4	A09	0.02	Customer Extracted	Q5	3.64	NA	3.64	8.2	8.2	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	ATGCTAACCACG	TGAGGATGATAG	IgA-IgM-IgG-	4A	run7	Y	NA	0.02	000000000-CD29D
I.63.2.Neg.5	TGAGGATGATAGAACTGCGATATG	GGACTACNVGGGTWTCTAAT	252	F63.2	FACS	Human	NA	Control	F63	NA	52319	P4	F09	0.01	Customer Extracted	Q5	9.74	NA	9.74	3.1	3.1	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	AACTGCGATATG	TGAGGATGATAG	IgA-IgM-IgG-	5A	run7	Y	NA	0.01	000000000-CD29D
I.E.03	TGAGGATGATAGTATGAACGTCCG	GGACTACNVGGGTWTCTAAT	E03	NA	SLP Control	NA	NA	NA	F3	NA	NA	P4	B12	0.05	Customer Extracted	Q5	4.61	NA	4.61	6.5	6.5	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	TATGAACGTCCG	TGAGGATGATAG	NA	NA	run1	Y	NA	0.05	000000000-CD29D
I.E.11	TGAGGATGATAGCCACATTGGGTC	GGACTACNVGGGTWTCTAAT	E11	NA	SLP Control	NA	NA	NA	F11	NA	NA	P4	C12	0	Customer Extracted	Q5	0.11	NA	0.11	272.7	35	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	CCACATTGGGTC	TGAGGATGATAG	NA	NA	run1	Y	NA	0	000000000-CD29D
I.E.14	TGAGGATGATAGTCAGTCAGATGA	GGACTACNVGGGTWTCTAAT	E14	NA	SLP Control	NA	NA	NA	F14	NA	NA	P4	D12	0.05	Customer Extracted	Q5	8.24	NA	8.24	3.6	3.6	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	TCAGTCAGATGA	TGAGGATGATAG	NA	NA	run2	Y	NA	0.05	000000000-CD29D
I.E.33	TGAGGATGATAGGCTGTGATTCGA	GGACTACNVGGGTWTCTAAT	E33	NA	SLP Control	NA	NA	NA	F33	NA	NA	P4	F12	0.03	Customer Extracted	Q5	8.25	NA	8.25	3.6	3.6	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	GCTGTGATTCGA	TGAGGATGATAG	NA	NA	run2	Y	NA	0.03	000000000-CD29D
I.E.36	TGAGGATGATAGCTAGCTATGGAC	GGACTACNVGGGTWTCTAAT	E36	NA	SLP Control	NA	NA	NA	F36	NA	NA	P4	G12	0.01	Customer Extracted	Q5	1.86	NA	1.86	16.1	16.1	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	CTAGCTATGGAC	TGAGGATGATAG	NA	NA	run3	Y	NA	0.01	000000000-CD29D
I.E.46	TGAGGATGATAGCTTGACGAGGTT	GGACTACNVGGGTWTCTAAT	E46	NA	SLP Control	NA	NA	NA	NA	NA	NA	P4	H12	0	Customer Extracted	Q5	0.74	NA	0.74	40.5	35	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	CTTGACGAGGTT	TGAGGATGATAG	NA	NA	run3	Y	NA	0	000000000-CD29D
I.E.48	GTAAGTCGTGGCCTACACAGCACA	GGACTACNVGGGTWTCTAAT	E48	NA	SLP Control	NA	NA	NA	NA	NA	NA	P1	B05	NA	Customer Extracted	Q5	0.11	NA	0.11	272.7	35	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	CTACACAGCACA	GTAAGTCGTGGC	NA	NA	run4	Y	NA	NA	000000000-CD29D
I.E.49	GTAAGTCGTGGCGAAATGCTACGT	GGACTACNVGGGTWTCTAAT	E49	NA	SLP Control	NA	NA	NA	NA	NA	NA	P1	C05	NA	Customer Extracted	Q5	0.05	NA	0.05	600	35	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	GAAATGCTACGT	GTAAGTCGTGGC	NA	NA	run7	Y	NA	NA	000000000-CD29D
I.E.50	GTAAGTCGTGGCTCTGAGGTTGCC	GGACTACNVGGGTWTCTAAT	E50	NA	SLP Control	NA	NA	NA	NA	NA	NA	P1	D05	NA	Customer Extracted	Q5	0.17	NA	0.17	176.5	35	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	TCTGAGGTTGCC	GTAAGTCGTGGC	NA	NA	run6	Y	NA	NA	000000000-CD29D
I.E.52	GTAAGTCGTGGCGATCATTCTCTC	GGACTACNVGGGTWTCTAAT	E52	NA	SLP Control	NA	NA	NA	NA	NA	NA	P1	E05	NA	Customer Extracted	Q5	0.14	NA	0.14	214.3	35	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	GATCATTCTCTC	GTAAGTCGTGGC	NA	NA	run6	Y	NA	NA	000000000-CD29D
I.E.54	GTAAGTCGTGGCAGACATACCGTA	GGACTACNVGGGTWTCTAAT	E54	NA	SLP Control	NA	NA	NA	NA	NA	NA	P1	F05	NA	Customer Extracted	Q5	0.12	NA	0.12	250	35	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	AGACATACCGTA	GTAAGTCGTGGC	NA	NA	run5	Y	NA	NA	000000000-CD29D
I.E.59	GTAAGTCGTGGCGATCCTCATGCG	GGACTACNVGGGTWTCTAAT	E59	NA	SLP Control	NA	NA	NA	NA	NA	NA	P1	G05	NA	Customer Extracted	Q5	0.08	NA	0.08	375	35	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	GATCCTCATGCG	GTAAGTCGTGGC	NA	NA	run5	Y	NA	NA	000000000-CD29D
I.E.63	GTAAGTCGTGGCATTATCGTCCCT	GGACTACNVGGGTWTCTAAT	E63	NA	SLP Control	NA	NA	NA	NA	NA	NA	P1	H05	NA	Customer Extracted	Q5	0.09	NA	0.09	333.3	35	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	ATTATCGTCCCT	GTAAGTCGTGGC	NA	NA	run7	Y	NA	NA	000000000-CD29D
I.S.03	TGAGGATGATAGACGGCGTTATGT	GGACTACNVGGGTWTCTAAT	S03	NA	Sheath	NA	NA	NA	F3	NA	NA	P4	C10	0.06	Customer Extracted	Q5	3.84	NA	3.84	7.8	7.8	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	ACGGCGTTATGT	TGAGGATGATAG	NA	NA	run1	Y	NA	0.06	000000000-CD29D
I.S.11	TGAGGATGATAGACTTTGCTTTGC	GGACTACNVGGGTWTCTAAT	S11	NA	Sheath	NA	NA	NA	F11	NA	NA	P4	D10	0	Customer Extracted	Q5	0.16	NA	0.16	187.5	35	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	ACTTTGCTTTGC	TGAGGATGATAG	NA	NA	run1	Y	NA	0	000000000-CD29D
I.S.14	TGAGGATGATAGCAAAGCGGTATT	GGACTACNVGGGTWTCTAAT	S14	NA	Sheath	NA	NA	NA	F14	NA	NA	P4	E10	0.05	Customer Extracted	Q5	7.47	NA	7.47	4	4	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	CAAAGCGGTATT	TGAGGATGATAG	NA	NA	run2	Y	NA	0.05	000000000-CD29D
I.S.33	TGAGGATGATAGCGAAACTACGTA	GGACTACNVGGGTWTCTAAT	S33	NA	Sheath	NA	NA	NA	F33	NA	NA	P4	F10	0.02	Customer Extracted	Q5	4.12	NA	4.12	7.3	7.3	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	CGAAACTACGTA	TGAGGATGATAG	NA	NA	run2	Y	NA	0.02	000000000-CD29D
I.S.36	TGAGGATGATAGGAGGACCAGCAA	GGACTACNVGGGTWTCTAAT	S36	NA	Sheath	NA	NA	NA	F36	NA	NA	P4	G10	0.01	Customer Extracted	Q5	6.17	NA	6.17	4.9	4.9	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	GAGGACCAGCAA	TGAGGATGATAG	NA	NA	run3	Y	NA	0.01	000000000-CD29D
I.S.46	TGAGGATGATAGAATAGCATGTCG	GGACTACNVGGGTWTCTAAT	S46	NA	Sheath	NA	NA	NA	NA	NA	NA	P4	H10	0.02	Customer Extracted	Q5	6.66	NA	6.66	4.5	4.5	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	AATAGCATGTCG	TGAGGATGATAG	NA	NA	run3	Y	NA	0.02	000000000-CD29D
I.S.47	TGAGGATGATAGCGGAGTAATCCT	GGACTACNVGGGTWTCTAAT	S47	NA	Sheath	NA	NA	NA	F47	NA	NA	P4	A11	0	Customer Extracted	Q5	0.14	NA	0.14	214.3	35	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	CGGAGTAATCCT	TGAGGATGATAG	NA	NA	run4	Y	NA	0	000000000-CD29D
I.S.48	TGAGGATGATAGCTGTGTCCATGG	GGACTACNVGGGTWTCTAAT	S48	NA	Sheath	NA	NA	NA	F48	NA	NA	P4	B11	0.01	Customer Extracted	Q5	6.88	NA	6.88	4.4	4.4	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	CTGTGTCCATGG	TGAGGATGATAG	NA	NA	run7	Y	NA	0.01	000000000-CD29D
I.S.49	TGAGGATGATAGCTTCGCGGATGT	GGACTACNVGGGTWTCTAAT	S49	NA	Sheath	NA	NA	NA	F49	NA	NA	P4	C11	0.01	Customer Extracted	Q5	0.23	NA	0.23	130.4	35	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	CTTCGCGGATGT	TGAGGATGATAG	NA	NA	run6	Y	NA	0.01	000000000-CD29D
I.S.50	TGAGGATGATAGATAGGCTGTAGT	GGACTACNVGGGTWTCTAAT	S50	NA	Sheath	NA	NA	NA	F50	NA	NA	P4	D11	0	Customer Extracted	Q5	0.13	NA	0.13	230.8	35	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	ATAGGCTGTAGT	TGAGGATGATAG	NA	NA	run6	Y	NA	0	000000000-CD29D
I.S.51	TGAGGATGATAGTGTGTAGCCATG	GGACTACNVGGGTWTCTAAT	S51	NA	Sheath	NA	NA	NA	F51	NA	NA	P4	E11	0.01	Customer Extracted	Q5	0.34	NA	0.34	88.2	35	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	TGTGTAGCCATG	TGAGGATGATAG	NA	NA	run7	Y	NA	0.01	000000000-CD29D
I.S.52	TGAGGATGATAGAAGGGCGCTGAA	GGACTACNVGGGTWTCTAAT	S52	NA	Sheath	NA	NA	NA	F52	NA	NA	P4	F11	0	Customer Extracted	Q5	0.18	NA	0.18	166.7	35	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	AAGGGCGCTGAA	TGAGGATGATAG	NA	NA	run6	Y	NA	0	000000000-CD29D
I.S.54	TGAGGATGATAGGTTTCCGTGGTG	GGACTACNVGGGTWTCTAAT	S54	NA	Sheath	NA	NA	NA	F54	NA	NA	P4	G11	0	Customer Extracted	Q5	0.11	NA	0.11	272.7	35	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	GTTTCCGTGGTG	TGAGGATGATAG	NA	NA	run5	Y	NA	0	000000000-CD29D
I.S.59	TGAGGATGATAGAGGAACCAGACG	GGACTACNVGGGTWTCTAAT	S59	NA	Sheath	NA	NA	NA	NA	NA	NA	P4	H11	0	Customer Extracted	Q5	0.11	NA	0.11	272.7	35	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	AGGAACCAGACG	TGAGGATGATAG	NA	NA	run5	Y	NA	0	000000000-CD29D
I.S.63	TGAGGATGATAGTAATGCCCAGGT	GGACTACNVGGGTWTCTAAT	S63	NA	Sheath	NA	NA	NA	F63	NA	NA	P4	A12	0	Customer Extracted	Q5	0.06	NA	0.06	500	35	TRUE	000000000-CD29D	20190701	Silvermen	19134	19138	TAATGCCCAGGT	TGAGGATGATAG	NA	NA	run7	Y	NA	0	000000000-CD29D
IDAHO.002.1	ATCTCTGGCATACTTCGCGGATGT	GGACTACNVGGGTWTCTAAT	NA	F2.1	Feces	Human	NA	IgA low	F2	NA	NA	CW.LD Plate 2	C11	1.49	customer extracted	Q5	7.93	NA	7.93	12.61	12.61	TRUE	000000000-C8T38	3/20/19	Silverman	18358	18359	CTTCGCGGATGT	ATCTCTGGCATA	NA	NA	run0719	N	NA	NA	000000000-C8T38
IDAHO.002.2	GTAAGTCGTGGCGATCTCTGGGTA	GGACTACNVGGGTWTCTAAT	NA	F2.2	Feces	Human	NA	IgA low	F2	NA	NA	P1	B03	6.99	Customer Extracted	Q5	39.97	NA	39.97	0.8	1	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	GATCTCTGGGTA	GTAAGTCGTGGC	NA	NA	NA	N	NA	6.99	000000000-CD29D
IDAHO.002.3	GTAAGTCGTGGCACGTGTAGGCTT	GGACTACNVGGGTWTCTAAT	2.3	F2.3	Feces	Human	NA	IgA low	F2	NA	NA	P1	H01	NA	Customer Extracted	Q5	33	NA	33	0.9	1	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	ACGTGTAGGCTT	GTAAGTCGTGGC	NA	NA	NA	N	NA	NA	000000000-CD29D
IDAHO.003.1	GTAAGTCGTGGCGCCGTCTCGTAA	GGACTACNVGGGTWTCTAAT	NA	F3.1	Feces	Human	NA	Case	F3	NA	NA	P1	H03	4.76	Customer Extracted	Q5	31.22	NA	31.22	1	1	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	GCCGTCTCGTAA	GTAAGTCGTGGC	NA	NA	NA	N	NA	4.76	000000000-CD29D
IDAHO.003.2	ATCTCTGGCATAGGTCTCCTACAG	GGACTACNVGGGTWTCTAAT	NA	F3.2	Feces	Human	NA	Case	F3	NA	NA	CW.LD Plate 2	A02	2.63	customer extracted	Q5	11.5	NA	11.5	8.7	8.7	TRUE	000000000-C8T38	3/20/19	Silverman	18358	18359	GGTCTCCTACAG	ATCTCTGGCATA	NA	NA	run0719	N	NA	NA	000000000-C8T38
IDAHO.005.1	GTAAGTCGTGGCAACCGCATAAGT	GGACTACNVGGGTWTCTAAT	NA	F5.1	Feces	Human	NA	IgA low	F5	NA	NA	P1	D04	1.17	Customer Extracted	Q5	14.58	NA	14.58	2.1	2.1	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	AACCGCATAAGT	GTAAGTCGTGGC	NA	NA	NA	N	NA	1.17	000000000-CD29D
IDAHO.005.2	ATCTCTGGCATATACGGATTATGG	GGACTACNVGGGTWTCTAAT	NA	F5.2	Feces	Human	NA	IgA low	F5	NA	NA	CW.LD Plate 2	D03	3.4	customer extracted	Q5	11	NA	11	9.09	9.09	TRUE	000000000-C8T38	3/20/19	Silverman	18358	18359	TACGGATTATGG	ATCTCTGGCATA	NA	NA	run0719	N	NA	NA	000000000-C8T38
IDAHO.005.3	GTAAGTCGTGGCCGCATTTGGATG	GGACTACNVGGGTWTCTAAT	NA	F5.3	Feces	Human	NA	IgA low	F5	NA	NA	P1	G04	7.21	Customer Extracted	Q5	41.54	NA	41.54	0.7	1	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	CGCATTTGGATG	GTAAGTCGTGGC	NA	NA	NA	N	NA	7.21	000000000-CD29D
IDAHO.006.1	GTAAGTCGTGGCACTGACTTAAGG	GGACTACNVGGGTWTCTAAT	6.1	F6.1	Feces	Human	NA	IgA low	F6	NA	NA	P1	B02	NA	Customer Extracted	Q5	35.8	NA	35.8	0.8	1	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	ACTGACTTAAGG	GTAAGTCGTGGC	NA	NA	NA	N	NA	NA	000000000-CD29D
IDAHO.006.2	ATCTCTGGCATATCGTGGATAGCT	GGACTACNVGGGTWTCTAAT	NA	F6.2	Feces	Human	NA	IgA low	F6	NA	NA	CW.LD Plate 2	D07	4.95	customer extracted	Q5	14.48	NA	14.48	6.91	6.91	TRUE	000000000-C8T38	3/20/19	Silverman	18358	18359	TCGTGGATAGCT	ATCTCTGGCATA	NA	NA	run0719	N	NA	NA	000000000-C8T38
IDAHO.007.1	GTAAGTCGTGGCATGGGCGAATGG	GGACTACNVGGGTWTCTAAT	NA	F7.1	Feces	Human	NA	IgA low	F7	NA	NA	P1	A03	3.79	Customer Extracted	Q5	0.06	NA	0.06	500	35	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	ATGGGCGAATGG	GTAAGTCGTGGC	NA	NA	NA	N	NA	3.79	000000000-CD29D
IDAHO.007.2	GTAAGTCGTGGCGAGCGTATCCAT	GGACTACNVGGGTWTCTAAT	NA	F7.2	Feces	Human	NA	IgA low	F7	NA	NA	P1	H02	1.04	Customer Extracted	Q5	0.06	NA	0.06	500	35	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	GAGCGTATCCAT	GTAAGTCGTGGC	NA	NA	NA	N	NA	1.04	000000000-CD29D
IDAHO.007.3	GTAAGTCGTGGCATAACATGTGCG	GGACTACNVGGGTWTCTAAT	NA	F7.3	Feces	Human	NA	IgA low	F7	NA	NA	P1	H04	1.84	Customer Extracted	Q5	36.03	NA	36.03	0.8	1	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	ATAACATGTGCG	GTAAGTCGTGGC	NA	NA	NA	N	NA	1.84	000000000-CD29D
IDAHO.007.4	ATCTCTGGCATAATAGGCTGTAGT	GGACTACNVGGGTWTCTAAT	NA	F7.4	Feces	Human	NA	IgA low	F7	NA	NA	CW.LD Plate 2	D11	4.75	customer extracted	Q5	12.41	NA	12.41	8.06	8.06	TRUE	000000000-C8T38	3/20/19	Silverman	18358	18359	ATAGGCTGTAGT	ATCTCTGGCATA	NA	NA	run0719	N	NA	NA	000000000-C8T38
IDAHO.010.1	ATCTCTGGCATATCAGTCAGATGA	GGACTACNVGGGTWTCTAAT	NA	F10.1	Feces	Human	NA	IgA low	F10	NA	NA	CW.LD Plate 2	D12	6.24	customer extracted	Q5	13.22	NA	13.22	7.56	7.56	TRUE	000000000-C8T38	3/20/19	Silverman	18358	18359	TCAGTCAGATGA	ATCTCTGGCATA	NA	NA	run0719	N	NA	NA	000000000-C8T38
IDAHO.010.2	ATCTCTGGCATACCAGATATAGCA	GGACTACNVGGGTWTCTAAT	NA	F10.2	Feces	Human	NA	IgA low	F10	NA	NA	CW.LD Plate 2	E01	2.22	customer extracted	Q5	8.27	NA	8.27	12.09	12.09	TRUE	000000000-C8T38	3/20/19	Silverman	18358	18359	CCAGATATAGCA	ATCTCTGGCATA	NA	NA	run0719	N	NA	NA	000000000-C8T38
IDAHO.011.1	ATCTCTGGCATAATGGGCGAATGG	GGACTACNVGGGTWTCTAAT	NA	F11.1	Feces	Human	NA	Control	F11	NA	NA	CW.LD Plate 2	A03	11.58	customer extracted	Q5	15.49	NA	15.49	6.46	6.46	TRUE	000000000-C8T38	3/20/19	Silverman	18358	18359	ATGGGCGAATGG	ATCTCTGGCATA	NA	NA	run0719	N	NA	NA	000000000-C8T38
IDAHO.011.2	ATCTCTGGCATACTTGAGAAATCG	GGACTACNVGGGTWTCTAAT	NA	F11.2	Feces	Human	NA	Case	F11	NA	NA	CW.LD Plate 2	A05	2.59	customer extracted	Q5	8.28	NA	8.28	12.08	12.08	TRUE	000000000-C8T38	3/20/19	Silverman	18358	18359	CTTGAGAAATCG	ATCTCTGGCATA	NA	NA	run0719	N	NA	NA	000000000-C8T38
IDAHO.014.1	GTAAGTCGTGGCACAGCTCAAACA	GGACTACNVGGGTWTCTAAT	NA	F14.1	Feces	Human	NA	Case	F14	NA	NA	P1	G02	3.54	Customer Extracted	Q5	32.6	NA	32.6	0.9	1	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	ACAGCTCAAACA	GTAAGTCGTGGC	NA	NA	NA	N	NA	3.54	000000000-CD29D
IDAHO.014.2	GTAAGTCGTGGCGTAGGTGCTTAC	GGACTACNVGGGTWTCTAAT	NA	F14.2	Feces	Human	NA	Control	F14	NA	NA	P1	F04	4.14	Customer Extracted	Q5	40.25	NA	40.25	0.7	1	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	GTAGGTGCTTAC	GTAAGTCGTGGC	NA	NA	NA	N	NA	4.14	000000000-CD29D
IDAHO.025.1	GTAAGTCGTGGCAATGACCTCGTG	GGACTACNVGGGTWTCTAAT	25.1	F25.1	Feces	Human	NA	IgA low	F25	NA	NA	P1	C01	NA	Customer Extracted	Q5	41.63	NA	41.63	0.7	1	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	AATGACCTCGTG	GTAAGTCGTGGC	NA	NA	NA	N	NA	NA	000000000-CD29D
IDAHO.025.2	GTAAGTCGTGGCACCTTACACCTT	GGACTACNVGGGTWTCTAAT	NA	F25.2	Feces	Human	NA	IgA low	F25	NA	NA	P1	E04	1.44	Customer Extracted	Q5	34.23	NA	34.23	0.9	1	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	ACCTTACACCTT	GTAAGTCGTGGC	NA	NA	NA	N	NA	1.44	000000000-CD29D
IDAHO.027.1	GTAAGTCGTGGCATTAAGCCTGGA	GGACTACNVGGGTWTCTAAT	27.1	F27.1	Feces	Human	NA	IgA low	F27	NA	NA	P1	E02	NA	Customer Extracted	Q5	28.85	NA	28.85	1	1	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	ATTAAGCCTGGA	GTAAGTCGTGGC	NA	NA	NA	N	NA	NA	000000000-CD29D
IDAHO.027.2	ATCTCTGGCATAGATCATTCTCTC	GGACTACNVGGGTWTCTAAT	NA	F27.2	Feces	Human	NA	IgA low	F27	NA	NA	CW.LD Plate 2	E05	10.57	customer extracted	Q5	14.27	NA	14.27	7.01	7.01	TRUE	000000000-C8T38	3/20/19	Silverman	18358	18359	GATCATTCTCTC	ATCTCTGGCATA	NA	NA	run0719	N	NA	NA	000000000-C8T38
IDAHO.033.1	ATCTCTGGCATACGCACTACGCAT	GGACTACNVGGGTWTCTAAT	NA	F33.1	Feces	Human	NA	Case	F33	NA	NA	CW.LD Plate 2	A08	4.57	customer extracted	Q5	12.54	NA	12.54	7.97	7.97	TRUE	000000000-C8T38	3/20/19	Silverman	18358	18359	CGCACTACGCAT	ATCTCTGGCATA	NA	NA	run0719	N	NA	NA	000000000-C8T38
IDAHO.033.2	GTAAGTCGTGGCCATCATACGGGT	GGACTACNVGGGTWTCTAAT	NA	F33.1	Feces	Human	NA	Control	F33	NA	NA	P1	C03	1.29	Customer Extracted	Q5	25.12	NA	25.12	1.2	1.2	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	CATCATACGGGT	GTAAGTCGTGGC	NA	NA	NA	N	NA	1.29	000000000-CD29D
IDAHO.034.1	GTAAGTCGTGGCTTCCTAGGCCAG	GGACTACNVGGGTWTCTAAT	34.1	F34.1	Feces	Human	NA	IgA low	F34	NA	NA	P1	D02	NA	Customer Extracted	Q5	42.48	NA	42.48	0.7	1	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	TTCCTAGGCCAG	GTAAGTCGTGGC	NA	NA	NA	N	NA	NA	000000000-CD29D
IDAHO.034.2	ATCTCTGGCATAGGCATGTTATCG	GGACTACNVGGGTWTCTAAT	NA	F34.2	Feces	Human	NA	IgA low	F34	NA	NA	CW.LD Plate 2	E08	1.21	customer extracted	Q5	8.31	NA	8.31	12.03	12.03	TRUE	000000000-C8T38	3/20/19	Silverman	18358	18359	GGCATGTTATCG	ATCTCTGGCATA	NA	NA	run0719	N	NA	NA	000000000-C8T38
IDAHO.036.1	ATCTCTGGCATATGTACATCGCCG	GGACTACNVGGGTWTCTAAT	NA	F36.1	Feces	Human	NA	Case	F36	NA	NA	CW.LD Plate 2	A10	4.44	customer extracted	Q5	10.29	NA	10.29	9.72	9.72	TRUE	000000000-C8T38	3/20/19	Silverman	18358	18359	TGTACATCGCCG	ATCTCTGGCATA	NA	NA	run0719	N	NA	NA	000000000-C8T38
IDAHO.036.2	ATCTCTGGCATACGGAGTAATCCT	GGACTACNVGGGTWTCTAAT	NA	F36.2	Feces	Human	NA	Control	F36	NA	NA	CW.LD Plate 2	A11	1.56	customer extracted	Q5	8.2	NA	8.2	12.2	12.2	TRUE	000000000-C8T38	3/20/19	Silverman	18358	18359	CGGAGTAATCCT	ATCTCTGGCATA	NA	NA	run0719	N	NA	NA	000000000-C8T38
IDAHO.039.1	GTAAGTCGTGGCCGATAGGCCTTA	GGACTACNVGGGTWTCTAAT	39.1	F39.1	Feces	Human	NA	IgA low	F39	NA	NA	P1	B01	NA	Customer Extracted	Q5	33.08	NA	33.08	0.9	1	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	CGATAGGCCTTA	GTAAGTCGTGGC	NA	NA	NA	N	NA	NA	000000000-CD29D
IDAHO.039.2	ATCTCTGGCATACAAAGCGGTATT	GGACTACNVGGGTWTCTAAT	NA	F39.2	Feces	Human	NA	IgA low	F39	NA	NA	CW.LD Plate 2	E10	6.96	customer extracted	Q5	13.82	NA	13.82	7.24	7.24	TRUE	000000000-C8T38	3/20/19	Silverman	18358	18359	CAAAGCGGTATT	ATCTCTGGCATA	NA	NA	run0719	N	NA	NA	000000000-C8T38
IDAHO.046.1	GTAAGTCGTGGCGACTACCCGTTG	GGACTACNVGGGTWTCTAAT	NA	F46.1	Feces	Human	NA	Case	F46	NA	NA	P1	B04	3.07	Customer Extracted	Q5	32.78	NA	32.78	0.9	1	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	GACTACCCGTTG	GTAAGTCGTGGC	NA	NA	NA	N	NA	3.07	000000000-CD29D
IDAHO.046.2	GTAAGTCGTGGCCCAGATATAGCA	GGACTACNVGGGTWTCTAAT	46.1	F46.2	Feces	Human	NA	Control	F46	NA	NA	P1	E01	NA	Customer Extracted	Q5	42.48	NA	42.48	0.7	1	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	CCAGATATAGCA	GTAAGTCGTGGC	NA	NA	NA	N	NA	NA	000000000-CD29D
IDAHO.047.1	GTAAGTCGTGGCACTCTAGCCGGT	GGACTACNVGGGTWTCTAAT	47.1	F47.1	Feces	Human	NA	Case	F47	NA	NA	P1	A01	NA	Customer Extracted	Q5	15.76	NA	15.76	1.9	1.9	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	ACTCTAGCCGGT	GTAAGTCGTGGC	NA	NA	NA	N	NA	NA	000000000-CD29D
IDAHO.047.2	ATCTCTGGCATAGATCTCTGGGTA	GGACTACNVGGGTWTCTAAT	NA	F47.2	Feces	Human	NA	Control	F47	NA	NA	CW.LD Plate 2	B03	2.65	customer extracted	Q5	9.82	NA	9.82	10.18	10.18	TRUE	000000000-C8T38	3/20/19	Silverman	18358	18359	GATCTCTGGGTA	ATCTCTGGCATA	NA	NA	run0719	N	NA	NA	000000000-C8T38
IDAHO.048.1	GTAAGTCGTGGCTACGGATTATGG	GGACTACNVGGGTWTCTAAT	NA	F48.1	Feces	Human	NA	Case	F48	NA	NA	P1	D03	1.36	Customer Extracted	Q5	33.57	NA	33.57	0.9	1	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	TACGGATTATGG	GTAAGTCGTGGC	NA	NA	NA	N	NA	1.36	000000000-CD29D
IDAHO.048.2	ATCTCTGGCATACTACACAGCACA	GGACTACNVGGGTWTCTAAT	NA	F48.2	Feces	Human	NA	Case	F48	NA	NA	CW.LD Plate 2	B05	2.25	customer extracted	Q5	9.75	NA	9.75	10.26	10.26	TRUE	000000000-C8T38	3/20/19	Silverman	18358	18359	CTACACAGCACA	ATCTCTGGCATA	NA	NA	run0719	N	NA	NA	000000000-C8T38
IDAHO.049.1	GTAAGTCGTGGCGAACGGGACGTA	GGACTACNVGGGTWTCTAAT	49.1	F49.1	Feces	Human	NA	Case	F49	NA	NA	P1	G01	NA	Customer Extracted	Q5	39.48	NA	39.48	0.8	1	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	GAACGGGACGTA	GTAAGTCGTGGC	NA	NA	NA	N	NA	NA	000000000-CD29D
IDAHO.049.2	ATCTCTGGCATATGTATCTTCACC	GGACTACNVGGGTWTCTAAT	NA	F49.2	Feces	Human	NA	Control	F49	NA	NA	CW.LD Plate 2	B07	2.85	customer extracted	Q5	13.07	NA	13.07	7.65	7.65	TRUE	000000000-C8T38	3/20/19	Silverman	18358	18359	TGTATCTTCACC	ATCTCTGGCATA	NA	NA	run0719	N	NA	NA	000000000-C8T38
IDAHO.049.3	ATCTCTGGCATACAGTCGTTAAGA	GGACTACNVGGGTWTCTAAT	NA	F49.3	Feces	Human	NA	Control	F49	NA	NA	CW.LD Plate 2	B08	1.91	customer extracted	Q5	10.6	NA	10.6	9.43	9.43	TRUE	000000000-C8T38	3/20/19	Silverman	18358	18359	CAGTCGTTAAGA	ATCTCTGGCATA	NA	NA	run0719	N	NA	NA	000000000-C8T38
IDAHO.050.1	ATCTCTGGCATAACCAATCTCGGC	GGACTACNVGGGTWTCTAAT	NA	F50.1	Feces	Human	NA	Case	F50	NA	NA	CW.LD Plate 2	B09	3.95	customer extracted	Q5	10.01	NA	10.01	9.99	9.99	TRUE	000000000-C8T38	3/20/19	Silverman	18358	18359	ACCAATCTCGGC	ATCTCTGGCATA	NA	NA	run0719	N	NA	NA	000000000-C8T38
IDAHO.050.2	GTAAGTCGTGGCTGGCTTTCTATC	GGACTACNVGGGTWTCTAAT	50.1	F50.2	Feces	Human	NA	Control	F50	NA	NA	P1	F02	NA	Customer Extracted	Q5	37.64	NA	37.64	0.8	1	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	TGGCTTTCTATC	GTAAGTCGTGGC	NA	NA	NA	N	NA	NA	000000000-CD29D
IDAHO.051.1	ATCTCTGGCATACTGTGTCCATGG	GGACTACNVGGGTWTCTAAT	NA	F51.1	Feces	Human	NA	Case	F51	NA	NA	CW.LD Plate 2	B11	1.79	customer extracted	Q5	9.1	NA	9.1	10.99	10.99	TRUE	000000000-C8T38	3/20/19	Silverman	18358	18359	CTGTGTCCATGG	ATCTCTGGCATA	NA	NA	run0719	N	NA	NA	000000000-C8T38
IDAHO.051.2	GTAAGTCGTGGCCTTAGGCATGTG	GGACTACNVGGGTWTCTAAT	51.2	F51.1	Feces	Human	NA	Control	F51	NA	NA	P1	D01	NA	Customer Extracted	Q5	38.19	NA	38.19	0.8	1	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	CTTAGGCATGTG	GTAAGTCGTGGC	NA	NA	NA	N	NA	NA	000000000-CD29D
IDAHO.052.1	ATCTCTGGCATAAATGACCTCGTG	GGACTACNVGGGTWTCTAAT	NA	F52.1	Feces	Human	NA	Case	F52	NA	NA	CW.LD Plate 2	C01	2.96	customer extracted	Q5	9.38	NA	9.38	10.66	10.66	TRUE	000000000-C8T38	3/20/19	Silverman	18358	18359	AATGACCTCGTG	ATCTCTGGCATA	NA	NA	run0719	N	NA	NA	000000000-C8T38
IDAHO.052.2	ATCTCTGGCATAGATGCTGCCGTT	GGACTACNVGGGTWTCTAAT	NA	F52.2	Feces	Human	NA	Control	F52	NA	NA	CW.LD Plate 2	C02	4.69	customer extracted	Q5	10.95	NA	10.95	9.13	9.13	TRUE	000000000-C8T38	3/20/19	Silverman	18358	18359	GATGCTGCCGTT	ATCTCTGGCATA	NA	NA	run0719	N	NA	NA	000000000-C8T38
IDAHO.052.3	ATCTCTGGCATACATCATACGGGT	GGACTACNVGGGTWTCTAAT	NA	F52.3	Feces	Human	NA	Control	F52	NA	NA	CW.LD Plate 2	C03	3.5	customer extracted	Q5	8.64	NA	8.64	11.57	11.57	TRUE	000000000-C8T38	3/20/19	Silverman	18358	18359	CATCATACGGGT	ATCTCTGGCATA	NA	NA	run0719	N	NA	NA	000000000-C8T38
IDAHO.054.1	GTAAGTCGTGGCGCGTTGCAAACT	GGACTACNVGGGTWTCTAAT	NA	F54.1	Feces	Human	NA	Case	F54	NA	NA	P1	C04	2.57	Customer Extracted	Q5	37.11	NA	37.11	0.8	1	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	GCGTTGCAAACT	GTAAGTCGTGGC	NA	NA	NA	N	NA	2.57	000000000-CD29D
IDAHO.054.2	GTAAGTCGTGGCGAGAGTCCACTT	GGACTACNVGGGTWTCTAAT	54.1	F54.2	Feces	Human	NA	Control	F54	NA	NA	P1	F01	NA	Customer Extracted	Q5	33.82	NA	33.82	0.9	1	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	GAGAGTCCACTT	GTAAGTCGTGGC	NA	NA	NA	N	NA	NA	000000000-CD29D
IDAHO.059.1	GTAAGTCGTGGCGGTCTCCTACAG	GGACTACNVGGGTWTCTAAT	59.1	F59.1	Feces	Human	NA	Case	F59	NA	NA	P1	A02	NA	Customer Extracted	Q5	33.93	NA	33.93	0.9	1	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	GGTCTCCTACAG	GTAAGTCGTGGC	NA	NA	NA	N	NA	NA	000000000-CD29D
IDAHO.059.2	GTAAGTCGTGGCTAACGCTGTGTG	GGACTACNVGGGTWTCTAAT	NA	F59.2	Feces	Human	NA	Control	F59	NA	NA	P1	F03	1.86	Customer Extracted	Q5	38.41	NA	38.41	0.8	1	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	TAACGCTGTGTG	GTAAGTCGTGGC	NA	NA	NA	N	NA	1.86	000000000-CD29D
IDAHO.063.1	GTAAGTCGTGGCATAGCGAACTCA	GGACTACNVGGGTWTCTAAT	NA	F63.1	Feces	Human	NA	Case	F63	NA	NA	P1	E03	4.79	Customer Extracted	Q5	34.26	NA	34.26	0.9	1	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	ATAGCGAACTCA	GTAAGTCGTGGC	NA	NA	NA	N	NA	4.79	000000000-CD29D
IDAHO.063.2	GTAAGTCGTGGCGATGCTGCCGTT	GGACTACNVGGGTWTCTAAT	63.2	F63.2	Feces	Human	NA	Control	F63	NA	NA	P1	C02	NA	Customer Extracted	Q5	40.12	NA	40.12	0.7	1	TRUE	000000000-CD29D	20190701	Silvermen	19131	19135	GATGCTGCCGTT	GTAAGTCGTGGC	NA	NA	NA	N	NA	NA	000000000-CD29D